


<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
         xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
    <responseDate>2025-09-09T13:49:04Z</responseDate>
    <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:12405024" metadataPrefix="pmc">https://pmc.ncbi.nlm.nih.gov/api/oai/v1/mh/</request>
    
    <GetRecord>
        <record>
    <header>
    <identifier>oai:pubmedcentral.nih.gov:12405024</identifier>
    <datestamp>2025-09-04</datestamp>
    
        
        <setSpec>pmc-open</setSpec>
        
    
</header>
    <metadata>
        
        <article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.4/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.4/ https://jats.nlm.nih.gov/archiving/1.4/xsd/JATS-archivearticle1-4.xsd" article-type="research-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">J Neurol</journal-id><journal-id journal-id-type="iso-abbrev">J Neurol</journal-id><journal-id journal-id-type="pmc-domain-id">365</journal-id><journal-id journal-id-type="pmc-domain">springeropen</journal-id><journal-title-group><journal-title>Journal of Neurology</journal-title></journal-title-group><issn pub-type="ppub">0340-5354</issn><issn pub-type="epub">1432-1459</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>Springer</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12405024</article-id><article-id pub-id-type="pmcid-ver">PMC12405024.1</article-id><article-id pub-id-type="pmcaid">12405024</article-id><article-id pub-id-type="pmcaiid">12405024</article-id><article-id pub-id-type="pmid">40892267</article-id><article-id pub-id-type="doi">10.1007/s00415-025-13337-0</article-id><article-id pub-id-type="publisher-id">13337</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Original Communication</subject></subj-group></article-categories><title-group><article-title>Olfactory function is longitudinally associated with semantic fluency in Parkinson&#8217;s disease: a cohort study</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-7961-1768</contrib-id><name name-style="western"><surname>Roos</surname><given-names initials="DS">Dareia S.</given-names></name><address><email>d.roos@amsterdamumc.nl</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Berendse</surname><given-names initials="HW">Henk W.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Doty</surname><given-names initials="RL">Richard L.</given-names></name><xref ref-type="aff" rid="Aff4">4</xref><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Twisk</surname><given-names initials="JWR">Jos W. R.</given-names></name><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Klein</surname><given-names initials="M">Martin</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00q6h8f30</institution-id><institution-id institution-id-type="GRID">grid.16872.3a</institution-id><institution-id institution-id-type="ISNI">0000 0004 0435 165X</institution-id><institution>Department of Neurology, </institution><institution>Amsterdam UMC Location Vrije Universiteit Amsterdam, </institution></institution-wrap>de Boelelaan 1117, 1081 HV Amsterdam, The Netherlands </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01x2d9f70</institution-id><institution-id institution-id-type="GRID">grid.484519.5</institution-id><institution>Amsterdam Neuroscience, Neurodegeneration, </institution></institution-wrap>Amsterdam, The Netherlands </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00q6h8f30</institution-id><institution-id institution-id-type="GRID">grid.16872.3a</institution-id><institution-id institution-id-type="ISNI">0000 0004 0435 165X</institution-id><institution>Department of Medical Psychology, </institution><institution>Amsterdam UMC Location Vrije Universiteit Amsterdam, </institution></institution-wrap>de Boelelaan 1117, 1081 HV Amsterdam, The Netherlands </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00b30xv10</institution-id><institution-id institution-id-type="GRID">grid.25879.31</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8972</institution-id><institution>Perelman School of Medicine, </institution><institution>University of Pennsylvania, </institution></institution-wrap>Philadelphia, USA </aff><aff id="Aff5"><label>5</label>Smell and Taste Evaluation Center, Haddon Heights, NJ USA </aff><aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00q6h8f30</institution-id><institution-id institution-id-type="GRID">grid.16872.3a</institution-id><institution-id institution-id-type="ISNI">0000 0004 0435 165X</institution-id><institution>Department of Epidemiology and Data Science, </institution><institution>Amsterdam UMC Location Vrije Universiteit Amsterdam, </institution></institution-wrap>de Boelelaan 1117, 1081 HV Amsterdam, The Netherlands </aff></contrib-group><pub-date pub-type="epub"><day>2</day><month>9</month><year>2025</year></pub-date><pub-date pub-type="ppub"><year>2025</year></pub-date><volume>272</volume><issue>9</issue><issue-id pub-id-type="pmc-issue-id">496088</issue-id><elocation-id>604</elocation-id><history><date date-type="received"><day>25</day><month>4</month><year>2025</year></date><date date-type="rev-recd"><day>13</day><month>8</month><year>2025</year></date><date date-type="accepted"><day>17</day><month>8</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>02</day><month>09</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>04</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-04 00:25:59.930"><day>04</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2025</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><self-uri content-type="pmc-pdf" xlink:href="415_2025_Article_13337.pdf"/><abstract id="Abs1"><sec><title>Background</title><p id="Par1">Olfactory dysfunction is an early, common, and progressive symptom in Parkinson&#8217;s disease (PD). Whether the decline in olfactory function is longitudinally associated with a deterioration of (non-)motor symptoms remains debated.</p></sec><sec><title>Objectives</title><p id="Par2">This study aimed to investigate the longitudinal relationship between olfactory function and (non-)motor symptoms, particularly cognitive decline, in PD patients over a ten-year follow-up period.</p></sec><sec><title>Methods</title><p id="Par3">Ninety patients were assessed at baseline and after approximately ten years. Olfactory function was measured using the 40-item University of Pennsylvania Smell Identification Test (UPSIT&#174;). (non-)Motor symptoms were evaluated using various scales and questionnaires, including the MMSE to assess global cognitive function. Linear regression was used to analyze the change in olfactory function over time in relation to changes in (non-)motor function, and to determine whether baseline olfactory test scores would be associated with (non-)motor function at follow-up. In a subset of 62 patients, in whom comprehensive cognitive testing was performed, we analyzed the longitudinal relationship between olfactory function and performance on specific cognitive tests.</p></sec><sec><title>Results</title><p id="Par4">Statistically significant associations were found between a decrease in UPSIT&#174; scores and decline in MMSE, and between baseline UPSIT&#174; scores and MMSE performance at follow-up. In the subgroup with comprehensive cognitive testing, a decrease in UPSIT&#174; scores was associated with worsening semantic fluency. Furthermore, an association was found between baseline UPSIT&#174; score and semantic fluency at follow-up.</p></sec><sec><title>Conclusions</title><p id="Par5">Decline in olfactory function in PD is longitudinally associated with worsening global cognitive function, particularly a deterioration in semantic fluency. Baseline olfactory function may be predictive of later cognitive decline, especially in the semantic domain.</p></sec><sec><title>Supplementary Information</title><p>The online version contains supplementary material available at 10.1007/s00415-025-13337-0.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Parkinson&#8217;s disease</kwd><kwd>Olfaction</kwd><kwd>Cognitive functioning</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100013891</institution-id><institution>Parkinson Vereniging</institution></institution-wrap></funding-source><award-id>2020-R-10</award-id><principal-award-recipient><name name-style="western"><surname>Berendse</surname><given-names>Henk W.</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; Springer-Verlag GmbH Germany, part of Springer Nature 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par6">With a prevalence of up to 90%, olfactory dysfunction is very common in patients with Parkinson&#8217;s disease (PD) [<xref ref-type="bibr" rid="CR1">1</xref>&#8211;<xref ref-type="bibr" rid="CR3">3</xref>]. Olfactory loss may precede the first disease-related motor symptoms by several years and is considered an early hallmark of the disease [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>]. However, the relationship between olfactory dysfunction and other motor and non-motor symptoms in PD remains incompletely understood.</p><p id="Par7">Previous cross-sectional research investigating the association between olfactory function and motor symptoms have yielded inconsistent results. While some studies have reported that the degree of hyposmia correlates with disease severity, as measured with the Unified PD Rating Scale motor subscale (UPDRS III) [<xref ref-type="bibr" rid="CR6">6</xref>&#8211;<xref ref-type="bibr" rid="CR10">10</xref>], others have found no significant association with disease stage or severity [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR11">11</xref>&#8211;<xref ref-type="bibr" rid="CR13">13</xref>].</p><p id="Par8">Similarly, studies exploring the relationship between olfactory function and neuropsychiatric symptoms in PD have produced conflicting findings. In one cross-sectional study, neuropsychiatric symptoms, except mood, were more common in patients with poor olfactory function [<xref ref-type="bibr" rid="CR14">14</xref>]. Conversely, two other studies failed to identify a significant correlation between olfactory dysfunction and psychiatric symptoms in PD [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>]. Other studies have suggested links between olfactory dysfunction and other non-motor symptoms, such as REM sleep behavior disorder [<xref ref-type="bibr" rid="CR17">17</xref>], constipation [<xref ref-type="bibr" rid="CR17">17</xref>], apathy,[<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR19">19</xref>], and autonomic failure [<xref ref-type="bibr" rid="CR20">20</xref>]. Poor olfactory function has also been associated with cognitive impairment [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR21">21</xref>&#8211;<xref ref-type="bibr" rid="CR23">23</xref>]. In a previous baseline analysis of the present cohort, we found significant associations between olfactory dysfunction and motor as well as non-motor symptoms, including cognitive decline, depression, anxiety, autonomic dysfunction, and sleep disturbances [<xref ref-type="bibr" rid="CR24">24</xref>].</p><p id="Par9">The cross-sectional nature of the aforementioned studies limits the ability to infer causality or temporal relationships between hyposmia and other motor and non-motor symptoms in PD. Longitudinal studies are crucial for understanding in what way olfactory dysfunction evolves over time and how it relates to the progression of motor and non-motor symptoms. While olfactory function is known to decline as PD progresses, its temporal association with other symptoms remains unclear [<xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR26">26</xref>]. Doty et al., for instance, observed no significant relationship between olfaction and disease stage or motor symptom severity over a 24-month follow-up period [<xref ref-type="bibr" rid="CR1">1</xref>]. In contrast, He et al. reported that hyposmic PD patients experienced more severe motor symptoms, required higher doses of dopaminergic medications, and showed poorer global cognition [<xref ref-type="bibr" rid="CR27">27</xref>], while a five-year study by Martinez-Nunez et al. found no association between olfactory dysfunction and apathy [<xref ref-type="bibr" rid="CR28">28</xref>]. A few studies have examined whether olfactory function at baseline would predict cognitive functioning over time. In most of these studies hyposmia was associated with an increased risk of dementia [<xref ref-type="bibr" rid="CR29">29</xref>&#8211;<xref ref-type="bibr" rid="CR31">31</xref>].</p><p id="Par10">These inconsistencies highlight the need for further investigation. Understanding which motor and non-motor symptoms are longitudinally associated with progressive olfactory decline may offer critical insights into the pathophysiological processes underlying PD. According to Braak&#8217;s staging hypothesis, alpha-synuclein pathology begins in the olfactory bulb, olfactory nucleus, and lower brainstem before spreading to cortical regions [<xref ref-type="bibr" rid="CR32">32</xref>]. This pattern suggests that as PD progresses, olfactory dysfunction and other symptoms may worsen concurrently.</p><p id="Par11">The objective of this study was to assess the longitudinal relationship between changes in olfactory function and changes in various motor and non-motor symptoms in PD over a ten-year follow-up period. In addition, we wanted to assess whether baseline olfactory function would be associated with motor and non-motor symptom severity ten years from baseline. By doing so, we aimed to deepen our understanding of the interplay between these symptoms and the pathological changes that occur over time in PD.</p></sec><sec id="Sec2"><title>Methods</title><sec id="Sec3"><title>Patients</title><p id="Par12">The baseline data for the present study were collected as part of routine clinical care in a cohort consisting of 295 PD patients who were recruited from the outpatient clinic for movement disorders at Amsterdam UMC, location Vrije Universiteit Amsterdam, between May 2008 and February 2014, as described in more detail elsewhere [<xref ref-type="bibr" rid="CR24">24</xref>]. The follow-up data for the study were obtained after an average interval of approximately ten years. A total of 90 patients, with a mean age of 58&#160;years, could be included. All other patients in the original cohort of 295 PD patients were either deceased (45%; <italic toggle="yes">n</italic>&#8201;=&#8201;133), declined to participate (22%; <italic toggle="yes">n</italic>&#8201;=&#8201;65), or were otherwise lost to follow-up (2%; <italic toggle="yes">n</italic>&#8201;=&#8201;7). Table <xref rid="Tab1" ref-type="table">1</xref> in the supplement shows the baseline characteristics of the patients included in the follow-up study compared to the patients that were lost to follow-up or declined to participate.
<table-wrap id="Tab1" position="float" orientation="portrait"><label>Table&#160;1</label><caption><p>Characteristics of the study population group</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1"/><th align="left" colspan="3" rowspan="1">Baseline</th><th align="left" colspan="3" rowspan="1">Follow-up</th></tr><tr><th align="left" colspan="1" rowspan="1"/><th align="left" colspan="1" rowspan="1"><italic toggle="yes">N</italic></th><th align="left" colspan="1" rowspan="1">Mean (SD)</th><th align="left" colspan="1" rowspan="1">Range</th><th align="left" colspan="1" rowspan="1"><italic toggle="yes">N</italic></th><th align="left" colspan="1" rowspan="1">Mean (SD)</th><th align="left" colspan="1" rowspan="1">Range</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Age, y</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">58.3 (9.4)</td><td align="left" colspan="1" rowspan="1">[27&#8211;74]</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">68.0 (9.4)</td><td align="left" colspan="1" rowspan="1">[37&#8211;84]</td></tr><tr><td align="left" colspan="1" rowspan="1">Males</td><td align="left" colspan="1" rowspan="1">62</td><td align="left" colspan="1" rowspan="1">68.9%</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Disease duration, y</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">4.5 (5.2)</td><td align="left" colspan="1" rowspan="1">[0&#8211;34]</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">14.2 (5.4)</td><td align="left" colspan="1" rowspan="1">[8&#8211;44]</td></tr><tr><td align="left" colspan="1" rowspan="1">LEDD, mg</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">227.4 (352)</td><td align="left" colspan="1" rowspan="1">[0&#8211;1255]</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">985.4 (504)</td><td align="left" colspan="1" rowspan="1">[200&#8211;2265]</td></tr><tr><td align="left" colspan="1" rowspan="1">UPSIT&#174; score</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">22.2 (7.6)</td><td align="left" colspan="1" rowspan="1">[3&#8211;36]</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">16.0 (5.5)</td><td align="left" colspan="1" rowspan="1">[6&#8211;33]</td></tr><tr><td align="left" colspan="1" rowspan="1">H&amp;Y stage</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Stage 1</td><td align="left" colspan="1" rowspan="1">17</td><td align="left" colspan="1" rowspan="1">18.9%</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Stage 1.5</td><td align="left" colspan="1" rowspan="1">12</td><td align="left" colspan="1" rowspan="1">13.3%</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Stage 2</td><td align="left" colspan="1" rowspan="1">46</td><td align="left" colspan="1" rowspan="1">51.1%</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">29</td><td align="left" colspan="1" rowspan="1">32.2%</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Stage 2.5</td><td align="left" colspan="1" rowspan="1">10</td><td align="left" colspan="1" rowspan="1">11.1%</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">27</td><td align="left" colspan="1" rowspan="1">30.0%</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Stage 3</td><td align="left" colspan="1" rowspan="1">5</td><td align="left" colspan="1" rowspan="1">5.6%</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">24</td><td align="left" colspan="1" rowspan="1">26.7%</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Stage 4</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">9</td><td align="left" colspan="1" rowspan="1">10.0%</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Stage 5</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">1</td><td align="left" colspan="1" rowspan="1">1.1%</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">UPDRS III</td><td align="left" colspan="1" rowspan="1">88</td><td align="left" colspan="1" rowspan="1">21.7 (10.6)</td><td align="left" colspan="1" rowspan="1">[4&#8211;46]</td><td align="left" colspan="1" rowspan="1">89</td><td align="left" colspan="1" rowspan="1">25.6 (11.9)</td><td align="left" colspan="1" rowspan="1">[6&#8211;66]</td></tr><tr><td align="left" colspan="1" rowspan="1">MMSE</td><td align="left" colspan="1" rowspan="1">88</td><td align="left" colspan="1" rowspan="1">28.6 (1.5)</td><td align="left" colspan="1" rowspan="1">[23&#8211;30]</td><td align="left" colspan="1" rowspan="1">87</td><td align="left" colspan="1" rowspan="1">27.1 (3.6)</td><td align="left" colspan="1" rowspan="1">[8&#8211;30]</td></tr><tr><td align="left" colspan="1" rowspan="1">SCOPA-SLEEP</td><td align="left" colspan="1" rowspan="1">84</td><td align="left" colspan="1" rowspan="1">11.1 (7.9)</td><td align="left" colspan="1" rowspan="1">[2&#8211;35]</td><td align="left" colspan="1" rowspan="1">89</td><td align="left" colspan="1" rowspan="1">12.8 (7.8)</td><td align="left" colspan="1" rowspan="1">[1&#8211;37]</td></tr><tr><td align="left" colspan="1" rowspan="1">SCOPA-AUT</td><td align="left" colspan="1" rowspan="1">86</td><td align="left" colspan="1" rowspan="1">11.0 (7.2)</td><td align="left" colspan="1" rowspan="1">[0&#8211;33]</td><td align="left" colspan="1" rowspan="1">88</td><td align="left" colspan="1" rowspan="1">16.1 (7.5)</td><td align="left" colspan="1" rowspan="1">[1&#8211;37]</td></tr><tr><td align="left" colspan="1" rowspan="1">SCOPA-PC</td><td align="left" colspan="1" rowspan="1">87</td><td align="left" colspan="1" rowspan="1">0.8 (1.1)</td><td align="left" colspan="1" rowspan="1">[0&#8211;5]</td><td align="left" colspan="1" rowspan="1">89</td><td align="left" colspan="1" rowspan="1">1.8 (1.9)</td><td align="left" colspan="1" rowspan="1">[0&#8211;9]</td></tr><tr><td align="left" colspan="1" rowspan="1">BAI</td><td align="left" colspan="1" rowspan="1">87</td><td align="left" colspan="1" rowspan="1">11.9 (9.2)</td><td align="left" colspan="1" rowspan="1">[0&#8211;41]</td><td align="left" colspan="1" rowspan="1">89</td><td align="left" colspan="1" rowspan="1">12.7 (11.3)</td><td align="left" colspan="1" rowspan="1">[0&#8211;37]</td></tr><tr><td align="left" colspan="1" rowspan="1">BDI</td><td align="left" colspan="1" rowspan="1">89</td><td align="left" colspan="1" rowspan="1">8.8 (7.4)</td><td align="left" colspan="1" rowspan="1">[0&#8211;44]</td><td align="left" colspan="1" rowspan="1">89</td><td align="left" colspan="1" rowspan="1">7.4 (5.8)</td><td align="left" colspan="1" rowspan="1">[0&#8211;38]</td></tr></tbody></table><table-wrap-foot><p><italic toggle="yes">LEDD</italic> levodopa equivalent daily dosage; <italic toggle="yes">H&amp;Y</italic> Hoehn &amp; Yahr; <italic toggle="yes">UPDRS III</italic> Unified Parkinson&#8217;s Disease Rating Scale motor subscale; <italic toggle="yes">MMSE</italic> Mini-Mental State Examination; <italic toggle="yes">SCOPA</italic> SCales for Outcomes in PArkinson&#8217;s Disease; <italic toggle="yes">AUT</italic> autonomic dysfunction; <italic toggle="yes">PC</italic>: Psychiatric complications; <italic toggle="yes">BAI</italic> Beck Anxiety Inventory; <italic toggle="yes">BDI</italic> Beck Depression Inventory</p></table-wrap-foot></table-wrap></p><p id="Par13">At the follow-up visit, all of the follow-up study patients still fulfilled the UK Parkinson&#8217;s Disease Brain Bank criteria for the clinical diagnosis of PD [<xref ref-type="bibr" rid="CR33">33</xref>], as determined by a neurologist specialized in movement disorders (DR). Follow-up visits were performed between August 2020 and June 2021, either at the patient&#8217;s home (<italic toggle="yes">n</italic>&#8201;=&#8201;44) or the outpatient clinic (<italic toggle="yes">n</italic>&#8201;=&#8201;46), depending on their individual preferences. This study was approved by the Medical Ethical Committee of Amsterdam UMC, location Vrije Universiteit Amsterdam (VUmc; 2020.012). All patients gave written informed consent.</p></sec><sec id="Sec4"><title>Olfactory testing</title><p id="Par14">The Dutch version of the University of Pennsylvania Smell Identification Test (UPSIT&#174;) was employed both at baseline and follow-up [<xref ref-type="bibr" rid="CR34">34</xref>]. This highly reliable self-administered forced-choice 40-item odor identification test (test&#8211;retest <italic toggle="yes">r</italic>&#8201;=&#8201;0.92) has been translated into over 60 languages including Dutch and is strongly correlated with odor detection threshold tests (e.g., phenyl ethyl alcohol <italic toggle="yes">r</italic>&#8201;=&#8201;0.89 [<xref ref-type="bibr" rid="CR34">34</xref>]; n-butanol <italic toggle="yes">r</italic>&#8201;=&#8201;0.92) [<xref ref-type="bibr" rid="CR35">35</xref>]. After scratching a patch containing microcapsules filled with odorant, the subject sniffs the released odorant, and has to choose one out of four response options. The total score is calculated by adding up all correct answers. At baseline, patients completed the UPSIT&#174; at home. When the UPSIT&#174; was incomplete, subjects were asked to fill in the missing items at the hospital. At follow-up, UPSIT&#174; testing was supervised and, when necessary, the researcher helped scratching the patch. In only one case, a single item was missing due to a manufacturing error; the average of the non-missing values was used to impute the missing value.</p></sec><sec id="Sec5"><title>Clinical profiling</title><sec id="Sec6"><title>Motor symptoms</title><p id="Par15">Clinical measures of disease severity were determined at baseline and follow-up. To assess motor symptom severity, we used the UPDRS III (range 0&#8211;108) [<xref ref-type="bibr" rid="CR36">36</xref>]. Patients were on medication when rated. Disease stage was defined using the modified Hoehn &amp; Yahr stage (H&amp;Y) [<xref ref-type="bibr" rid="CR37">37</xref>]. Disease duration in years was measured from the onset of subjective motor symptoms.</p><p id="Par16">To calculate the levodopa equivalent daily dose (LEDD) the total dose of dopaminergic medication was converted using the following conversion rate: 100&#160;mg levodopa equaling 133.33&#160;mg levodopa with controlled release, 1&#160;mg pramipexol (as salt), 5&#160;mg ropinirole, 3.3&#160;mg rotigotine, and 100&#160;mg amantadine. Additionally, 10% was added to the total levodopa dose in case of the use of selegiline, rasagiline or safinamide, while 20% was added to the total levodopa dose in case of the use of a catechol-O-methyl transferase (COMT) inhibitor [<xref ref-type="bibr" rid="CR38">38</xref>].</p></sec><sec id="Sec7"><title>Cognitive function</title><p id="Par17">Global cognitive function was tested using the Mini-Mental State Examination (MMSE)[<xref ref-type="bibr" rid="CR39">39</xref>] at baseline and follow-up. At baseline, comprehensive cognitive testing was performed in a subgroup of patients for whom this was deemed clinically necessary, as per the referring physician. At follow-up, comprehensive cognitive testing was performed in 62 patients. As a result, since not all patients performed comprehensive cognitive testing at baseline, test outcomes of 52 patients on the following tests were available both at baseline and follow-up: attention and working memory (Digit Span forward and backward[<xref ref-type="bibr" rid="CR40">40</xref>] and Stroop Color-Word test[<xref ref-type="bibr" rid="CR41">41</xref>]), executive function (phonemic fluency[<xref ref-type="bibr" rid="CR42">42</xref>] and semantic fluency[<xref ref-type="bibr" rid="CR42">42</xref>]), and verbal memory (Rey&#8217;s Auditory Verbal Learning Test delayed recall [RAVLT][<xref ref-type="bibr" rid="CR43">43</xref>]). The level of education was classified using the system of Verhage, ranging from level 1 (elementary school not finished) to level 7 (university) [<xref ref-type="bibr" rid="CR44">44</xref>].</p></sec><sec id="Sec8"><title>Other non-motor symptoms</title><p id="Par18">To assess autonomic symptoms the SCales for Outcomes in PArkinson&#8217;s disease Autonomic dysfunction (SCOPA-AUT) was used [<xref ref-type="bibr" rid="CR45">45</xref>]. Sleep disturbances were assessed using the SCales for Outcomes in PArkinson&#8217;s disease for sleep (SCOPA-SLEEP) [<xref ref-type="bibr" rid="CR46">46</xref>]. The SCales for Outcomes in PArkinson&#8217;s disease Psychiatric Complication (SCOPA-PC) was used to evaluate psychiatric symptoms [<xref ref-type="bibr" rid="CR47">47</xref>]. We rated depressive symptoms and anxiety symptoms using the Beck Depression Inventory (BDI) [<xref ref-type="bibr" rid="CR48">48</xref>] and the Beck Anxiety Inventory (BAI) [<xref ref-type="bibr" rid="CR49">49</xref>], respectively. All tests of non-motor function were performed at baseline and follow-up. For all tests except cognitive testing, a higher score reflects more severe symptoms.</p></sec></sec><sec id="Sec9"><title>Statistical analysis</title><p id="Par19">The data were analyzed using SPSS version 28.0 (SPSS Inc., Chicago, IL, USA). The significance level.</p><p id="Par20">was set at 0.05.</p><p id="Par21">The baseline demographic characteristics of the PD patients that were included in the follow-up study and the patients that could not be included were compared using an independent <italic toggle="yes">t</italic>-test, Mann&#8211;Whitney <italic toggle="yes">U</italic> test, or Chi-square test, depending on the distribution of the data (supplement Table&#160;<xref rid="MOESM1" ref-type="media">1</xref>). The same tests were used to compare the demographics of the group of patients with comprehensive cognitive testing versus the participants without these additional tests (supplement Table&#160;<xref rid="MOESM1" ref-type="media">2</xref>).</p><p id="Par22">The mean scores at baseline and follow-up for the various motor, non-motor, and comprehensive cognitive tests were calculated. Additionally, we examined whether the differences between baseline and follow-up were statistically significant.</p><p id="Par23">To analyze the longitudinal relationship between change in olfactory test scores and the changes in motor and other non-motor symptoms, a linear regression analysis was used. For each variable, three analyses were performed: the first uncorrected (model 1), the second adjusted for age and sex (model 2), and the third further adjusted for disease duration (model 3).</p><p id="Par24">In the subgroup of patients in whom comprehensive cognitive testing had been performed, we additionally tested the longitudinal relationship between change in olfactory test scores and change in the different specific cognitive test outcomes. Neuropsychological test results were first transformed to t-scores, which included a correction for educational level and, depending on the test psychometrics, also a correction for age and/or sex.</p><p id="Par25">To analyze the relationship between baseline olfactory function and the various motor and non-motor variables at follow-up, a linear regression analysis was used. For each variable, four analyses were performed: the first three according to the method described above, with the addition of a fourth model in which an additional adjustment for the interval between baseline and follow-up visit was used. Data from the SCOPA-SLEEP and the BDI were first log transformed because of non-normally distributed residuals. Lastly, in the subgroup of patients in whom comprehensive cognitive testing had been performed, we also used a linear regression with the same models described above to analyze whether baseline olfactory test scores would be associated with the different specific cognitive test scores at follow-up. This group consisted of 62 patients.</p></sec></sec><sec id="Sec10"><title>Results</title><sec id="Sec11"><title>Clinical characteristics</title><p id="Par26">The mean age of the patients at follow-up was 68&#160;years, with a mean disease duration of 14&#160;years. As expected, the LEDD was higher at follow-up than at baseline (Table&#160;<xref rid="Tab1" ref-type="table">1</xref>). The subgroup of patients who underwent comprehensive cognitive testing at follow-up were younger at baseline, were more often male, had a higher baseline MMSE score, and had a similar disease duration and LEDD compared to patients who did not undergo comprehensive cognitive testing at follow-up (Supplement Table&#160;<xref rid="Tab2" ref-type="table">2</xref>).
<table-wrap id="Tab2" position="float" orientation="portrait"><label>Table&#160;2</label><caption><p>Results of the linear regression analyses relating change in UPSIT&#174; score to change in motor and non-motor variables</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1"/><th align="left" colspan="1" rowspan="1">N</th><th align="left" colspan="1" rowspan="1"/><th align="left" colspan="1" rowspan="1">&#946;</th><th align="left" colspan="1" rowspan="1">B (95% CI)</th><th align="left" colspan="1" rowspan="1">Sign. (<italic toggle="yes">p</italic>)</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">UPDRS III</td><td align="left" colspan="1" rowspan="1">87</td><td align="left" colspan="1" rowspan="1">Model 1</td><td char="." align="char" colspan="1" rowspan="1">0.071</td><td align="left" colspan="1" rowspan="1">0.152 (&#8722;0.309; 0.614)</td><td char="." align="char" colspan="1" rowspan="1">0.513</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Model 2</td><td char="." align="char" colspan="1" rowspan="1">0.090</td><td align="left" colspan="1" rowspan="1">0.194 (&#8722;0.271; 0.658)</td><td char="." align="char" colspan="1" rowspan="1">0.410</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Model 3</td><td char="." align="char" colspan="1" rowspan="1">0.090</td><td align="left" colspan="1" rowspan="1">0.193 (&#8722;0.274; 0.661)</td><td char="." align="char" colspan="1" rowspan="1">0.413</td></tr><tr><td align="left" colspan="1" rowspan="1">MMSE</td><td align="left" colspan="1" rowspan="1">85</td><td align="left" colspan="1" rowspan="1">Model 1</td><td char="." align="char" colspan="1" rowspan="1">&#8722;0.204</td><td align="left" colspan="1" rowspan="1">&#8722;0.114 (&#8722;0.233; 0.005)</td><td char="." align="char" colspan="1" rowspan="1">0.061</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Model 2</td><td char="." align="char" colspan="1" rowspan="1">&#8722;0.226</td><td align="left" colspan="1" rowspan="1">&#8722;0.126 (&#8722;0.247; &#8722;0.004)</td><td char="." align="char" colspan="1" rowspan="1">0.043*</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Model 3</td><td char="." align="char" colspan="1" rowspan="1">&#8722;0.226</td><td align="left" colspan="1" rowspan="1">&#8722;0.126 (&#8722;0.247; &#8722;0.005)</td><td char="." align="char" colspan="1" rowspan="1">0.042*</td></tr><tr><td align="left" colspan="1" rowspan="1">SCOPA-SLEEP</td><td align="left" colspan="1" rowspan="1">82</td><td align="left" colspan="1" rowspan="1">Model 1</td><td char="." align="char" colspan="1" rowspan="1">0.092</td><td align="left" colspan="1" rowspan="1">0.145 (&#8722;0.206; 0.496)</td><td char="." align="char" colspan="1" rowspan="1">0.413</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Model 2</td><td char="." align="char" colspan="1" rowspan="1">0.088</td><td align="left" colspan="1" rowspan="1">0.140 (&#8722;0.216; 0.495)</td><td char="." align="char" colspan="1" rowspan="1">0.437</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Model 3</td><td char="." align="char" colspan="1" rowspan="1">0.088</td><td align="left" colspan="1" rowspan="1">0.139 (&#8722;0.218; 0.496)</td><td char="." align="char" colspan="1" rowspan="1">0.441</td></tr><tr><td align="left" colspan="1" rowspan="1">SCOPA-AUT</td><td align="left" colspan="1" rowspan="1">84</td><td align="left" colspan="1" rowspan="1">Model 1</td><td char="." align="char" colspan="1" rowspan="1">&#8722;0.050</td><td align="left" colspan="1" rowspan="1">&#8722;0.065 (&#8722;0.353; 0.223)</td><td char="." align="char" colspan="1" rowspan="1">0.653</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Model 2</td><td char="." align="char" colspan="1" rowspan="1">&#8722;0.026</td><td align="left" colspan="1" rowspan="1">&#8722;0.034 (&#8722;0.324; 0.256)</td><td char="." align="char" colspan="1" rowspan="1">0.815</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Model 3</td><td char="." align="char" colspan="1" rowspan="1">&#8722;0.026</td><td align="left" colspan="1" rowspan="1">&#8722;0.035 (&#8722;0.327; 0.257)</td><td char="." align="char" colspan="1" rowspan="1">0.814</td></tr><tr><td align="left" colspan="1" rowspan="1">SCOPA-PC</td><td align="left" colspan="1" rowspan="1">86</td><td align="left" colspan="1" rowspan="1">Model 1</td><td char="." align="char" colspan="1" rowspan="1">&#8722;0.106</td><td align="left" colspan="1" rowspan="1">&#8722;0.036 (&#8722;0.109; 0.037)</td><td char="." align="char" colspan="1" rowspan="1">0.330</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Model 2</td><td char="." align="char" colspan="1" rowspan="1">&#8722;0.100</td><td align="left" colspan="1" rowspan="1">&#8722;0.034 (&#8722;0.106; 0.039)</td><td char="." align="char" colspan="1" rowspan="1">0.356</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Model 3</td><td char="." align="char" colspan="1" rowspan="1">&#8722;0.102</td><td align="left" colspan="1" rowspan="1">&#8722;0.034 (&#8722;0.107; 0.039)</td><td char="." align="char" colspan="1" rowspan="1">0.352</td></tr><tr><td align="left" colspan="1" rowspan="1">BAI</td><td align="left" colspan="1" rowspan="1">86</td><td align="left" colspan="1" rowspan="1">Model 1</td><td char="." align="char" colspan="1" rowspan="1">&#8722;0.137</td><td align="left" colspan="1" rowspan="1">&#8722;0.311 (&#8722;0.798; 0.177)</td><td char="." align="char" colspan="1" rowspan="1">0.209</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Model 2</td><td char="." align="char" colspan="1" rowspan="1">&#8722;0.124</td><td align="left" colspan="1" rowspan="1">&#8722;0.281 (&#8722;0.782; 0.221)</td><td char="." align="char" colspan="1" rowspan="1">0.269</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Model 3</td><td char="." align="char" colspan="1" rowspan="1">&#8722;0.109</td><td align="left" colspan="1" rowspan="1">&#8722;0.248 (&#8722;0.714; 0.217)</td><td char="." align="char" colspan="1" rowspan="1">0.292</td></tr><tr><td align="left" colspan="1" rowspan="1">BDI</td><td align="left" colspan="1" rowspan="1">88</td><td align="left" colspan="1" rowspan="1">Model 1</td><td char="." align="char" colspan="1" rowspan="1">&#8722;0.017</td><td align="left" colspan="1" rowspan="1">&#8722;0.020 (&#8722;0.274; 0.235)</td><td char="." align="char" colspan="1" rowspan="1">0.877</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Model 2</td><td char="." align="char" colspan="1" rowspan="1">&#8722;0.007</td><td align="left" colspan="1" rowspan="1">&#8722;0.008 (&#8722;0.272; 0.255)</td><td char="." align="char" colspan="1" rowspan="1">0.950</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Model 3</td><td char="." align="char" colspan="1" rowspan="1">&#8722;0.007</td><td align="left" colspan="1" rowspan="1">&#8722;0.008 (&#8722;0.273; 0.257)</td><td char="." align="char" colspan="1" rowspan="1">0.954</td></tr></tbody></table><table-wrap-foot><p>Model 1 for UPSIT&#174; only</p><p>Model 2: adjusted for sex and age</p><p>Model 3: as model 2 with adjustment for disease duration</p><p>&#914; standardized coefficient; B unstandardized coefficient; <italic toggle="yes">CI</italic>confidence interval</p><p>*Significant (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05)</p><p><italic toggle="yes">UPDRS III</italic> Unified Parkinson&#8217;s Disease Rating Scale motor subscale, <italic toggle="yes">MMSE</italic> Mini-Mental State Examination, <italic toggle="yes">SCOPA</italic> SCales for Outcomes in PArkinson&#8217;s Disease, <italic toggle="yes">AUT</italic> Autonomic dysfunction, <italic toggle="yes">PC</italic> Psychiatric complications, <italic toggle="yes">BAI</italic> Beck Anxiety Inventory, <italic toggle="yes">BDI</italic> Beck Depression Inventory</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec12"><title>Relationship between change in olfactory function and change in (non-)motor symptoms</title><p id="Par27">Between baseline and follow-up, most measures of motor and non-motor symptoms showed an increase in symptom severity, except BDI and both forward and reverse digit span tests (Table&#160;<xref rid="Tab1" ref-type="table">1</xref>, supplement Table&#160;<xref rid="Tab3" ref-type="table">3</xref>).
<table-wrap id="Tab3" position="float" orientation="portrait"><label>Table&#160;3</label><caption><p>Results of the linear regression analyses relating change in UPSIT&#174; score to change in test scores on specific cognitive tests</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1"/><th align="left" colspan="1" rowspan="1">N</th><th align="left" colspan="1" rowspan="1"/><th align="left" colspan="1" rowspan="1">&#946;</th><th align="left" colspan="1" rowspan="1">B (95% CI)</th><th align="left" colspan="1" rowspan="1">Sign. (<italic toggle="yes">p</italic>)</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Rey&#8217;s Auditory Verbal Learning Test</td><td align="left" colspan="1" rowspan="1">51</td><td align="left" colspan="1" rowspan="1">Model 1</td><td align="left" colspan="1" rowspan="1">&#8722;0.138</td><td align="left" colspan="1" rowspan="1">&#8722;0.281 (&#8722;0.862; 0.299)</td><td char="." align="char" colspan="1" rowspan="1">0.335</td></tr><tr><td align="left" colspan="1" rowspan="1">delayed recall</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Model 2</td><td align="left" colspan="1" rowspan="1">&#8722;0.025</td><td align="left" colspan="1" rowspan="1">&#8722;0.052 (&#8722;0.617; 0.513)</td><td char="." align="char" colspan="1" rowspan="1">0.855</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Model 3</td><td align="left" colspan="1" rowspan="1">&#8722;0.025</td><td align="left" colspan="1" rowspan="1">&#8722;0.052 (&#8722;0.623; 0.520)</td><td char="." align="char" colspan="1" rowspan="1">0.857</td></tr><tr><td align="left" colspan="1" rowspan="1">Stroop Color-Word test</td><td align="left" colspan="1" rowspan="1">50</td><td align="left" colspan="1" rowspan="1">Model 1</td><td align="left" colspan="1" rowspan="1">&#8722;0.057</td><td align="left" colspan="1" rowspan="1">&#8722;0.092 (&#8722;0.563; 0.379)</td><td char="." align="char" colspan="1" rowspan="1">0.696</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Model 2</td><td align="left" colspan="1" rowspan="1">0.074</td><td align="left" colspan="1" rowspan="1">0.121 (&#8722;0.346; 0.587)</td><td char="." align="char" colspan="1" rowspan="1">0.606</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Model 3</td><td align="left" colspan="1" rowspan="1">0.074</td><td align="left" colspan="1" rowspan="1">0.120 (&#8722;0.350; 0.591)</td><td char="." align="char" colspan="1" rowspan="1">0.609</td></tr><tr><td align="left" colspan="1" rowspan="1">Forward Digit Span</td><td align="left" colspan="1" rowspan="1">52</td><td align="left" colspan="1" rowspan="1">Model 1</td><td align="left" colspan="1" rowspan="1">&#8722;0.156</td><td align="left" colspan="1" rowspan="1">&#8722;0.369 (&#8722;1.035; 0.296)</td><td char="." align="char" colspan="1" rowspan="1">0.270</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Model 2</td><td align="left" colspan="1" rowspan="1">&#8722;0.172</td><td align="left" colspan="1" rowspan="1">&#8722;0.408 (&#8722;1.103; 0.287)</td><td char="." align="char" colspan="1" rowspan="1">0.244</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Model 3</td><td align="left" colspan="1" rowspan="1">&#8722;0.175</td><td align="left" colspan="1" rowspan="1">&#8722;0.414 (&#8722;1.096; 0.268)</td><td char="." align="char" colspan="1" rowspan="1">0.228</td></tr><tr><td align="left" colspan="1" rowspan="1">Reverse Digit Span</td><td align="left" colspan="1" rowspan="1">52</td><td align="left" colspan="1" rowspan="1">Model 1</td><td align="left" colspan="1" rowspan="1">0.004</td><td align="left" colspan="1" rowspan="1">0.008 (&#8722;0.560; 0.575)</td><td char="." align="char" colspan="1" rowspan="1">0.978</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Model 2</td><td align="left" colspan="1" rowspan="1">0.049</td><td align="left" colspan="1" rowspan="1">0.098 (&#8722;0.496; 0.692)</td><td char="." align="char" colspan="1" rowspan="1">0.742</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Model 3</td><td align="left" colspan="1" rowspan="1">0.049</td><td align="left" colspan="1" rowspan="1">0.099 (&#8722;0.501; 0.698)</td><td char="." align="char" colspan="1" rowspan="1">0.742</td></tr><tr><td align="left" colspan="1" rowspan="1">Phonemic fluency</td><td align="left" colspan="1" rowspan="1">50</td><td align="left" colspan="1" rowspan="1">Model 1</td><td align="left" colspan="1" rowspan="1">0.017</td><td align="left" colspan="1" rowspan="1">0.031 (&#8722;0.484; 0.545)</td><td char="." align="char" colspan="1" rowspan="1">0.906</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Model 2</td><td align="left" colspan="1" rowspan="1">&#8722;0.101</td><td align="left" colspan="1" rowspan="1">&#8722;0.178 (&#8722;0.685; 0.328)</td><td char="." align="char" colspan="1" rowspan="1">0.482</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Model 3</td><td align="left" colspan="1" rowspan="1">&#8722;0.098</td><td align="left" colspan="1" rowspan="1">&#8722;0.174 (&#8722;0.675; 0.328)</td><td char="." align="char" colspan="1" rowspan="1">0.489</td></tr><tr><td align="left" colspan="1" rowspan="1">Semantic fluency</td><td align="left" colspan="1" rowspan="1">50</td><td align="left" colspan="1" rowspan="1">Model 1</td><td align="left" colspan="1" rowspan="1">&#8722;0.291</td><td align="left" colspan="1" rowspan="1">&#8722;0.600 (&#8722;1.172; &#8722;0.027)</td><td char="." align="char" colspan="1" rowspan="1">0.040*</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Model 2</td><td align="left" colspan="1" rowspan="1">&#8722;0.371</td><td align="left" colspan="1" rowspan="1">&#8722;0.764 (&#8722;1.298; &#8722;0.230)</td><td char="." align="char" colspan="1" rowspan="1">0.006*</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Model 3</td><td align="left" colspan="1" rowspan="1">&#8722;0.369</td><td align="left" colspan="1" rowspan="1">&#8722;0.761 (&#8722;1.299; &#8722;0.223)</td><td char="." align="char" colspan="1" rowspan="1">0.007*</td></tr></tbody></table><table-wrap-foot><p>Model 1 for UPSIT&#174; only</p><p>Model 2: adjusted for sex and age</p><p>Model 3: as model 2 with adjustment for disease duration</p><p>&#914; standardized coefficient; B unstandardized coefficient; <italic toggle="yes">CI</italic> confidence interval.</p><p>*Significant (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05)</p></table-wrap-foot></table-wrap></p><p id="Par28">The decline in UPSIT&#174; test scores over the follow-up period was significantly associated with a decline in MMSE score in both model 2, correcting for sex and age, and model 3, that corrected also for disease duration. The association did not survive a Bonferroni correction for multiple comparisons. There were no statistically significant relationships between change in UPSIT&#174; scores and changes in any of the other motor or non-motor variables (Table&#160;<xref rid="Tab2" ref-type="table">2</xref>).</p><p id="Par29">In the subgroup of patients in whom comprehensive cognitive testing had been performed both at baseline and follow-up (<italic toggle="yes">n</italic>&#8201;=&#8201;52), the decrease in UPSIT&#174; scores associated significantly with a decline in semantic fluency, in all models (Table&#160;<xref rid="Tab3" ref-type="table">3</xref>, Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>), and also after applying a Bonferroni correction. There were no significant correlations with any of the other cognitive outcome measures.<fig id="Fig1" position="float" orientation="portrait"><label>Fig.&#160;1</label><caption><p>Scatterplot showing the relation between change in UPSIT&#174; score and change in semantic fluency</p></caption><graphic id="MO1" position="float" orientation="portrait" xlink:href="415_2025_13337_Fig1_HTML.jpg"/></fig></p></sec><sec id="Sec13"><title>Relationship between baseline olfactory function and severity of (non-)motor symptoms ten years from baseline</title><p id="Par30">Baseline olfactory function was significantly associated with MMSE score and autonomic symptom severity at follow-up in all models at follow-up (Table&#160;<xref rid="Tab4" ref-type="table">4</xref>). Furthermore, an association was found between baseline olfactory test score and UPDRS III and SCOPA-PC scores ten years from baseline in model 4. When applying a Bonferroni correction, only the association between baseline olfactory test scores and MMSE remained significant.
<table-wrap id="Tab4" position="float" orientation="portrait"><label>Table&#160;4</label><caption><p>Results of the linear regression analyses relating baseline UPSIT&#174; score to various motor and non-motor variables at follow-up</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1"/><th align="left" colspan="1" rowspan="1">N</th><th align="left" colspan="1" rowspan="1"/><th align="left" colspan="1" rowspan="1">&#946;</th><th align="left" colspan="1" rowspan="1">B (95% CI)</th><th align="left" colspan="1" rowspan="1">Sign. (<italic toggle="yes">p</italic>)</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">UPDRS III</td><td align="left" colspan="1" rowspan="1">89</td><td align="left" colspan="1" rowspan="1">Model 1</td><td align="left" colspan="1" rowspan="1">&#8722;0.415</td><td align="left" colspan="1" rowspan="1">&#8722;0.644 (&#8722;0.945; &#8722;0.343)</td><td char="." align="char" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001*</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Model 2</td><td align="left" colspan="1" rowspan="1">&#8722;0.233</td><td align="left" colspan="1" rowspan="1">&#8722;0.361 (&#8722;0.688; &#8722;0.034)</td><td char="." align="char" colspan="1" rowspan="1">0.031*</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Model 3</td><td align="left" colspan="1" rowspan="1">&#8722;0.210</td><td align="left" colspan="1" rowspan="1">&#8722;0.325 (&#8722;0.658; 0.007)</td><td char="." align="char" colspan="1" rowspan="1">0.055</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Model 4</td><td align="left" colspan="1" rowspan="1">&#8722;0.244</td><td align="left" colspan="1" rowspan="1">&#8722;0.379 (&#8722;0.717; &#8722;0.041)</td><td char="." align="char" colspan="1" rowspan="1">0.028*</td></tr><tr><td align="left" colspan="1" rowspan="1">MMSE</td><td align="left" colspan="1" rowspan="1">87</td><td align="left" colspan="1" rowspan="1">Model 1</td><td align="left" colspan="1" rowspan="1">0.463</td><td align="left" colspan="1" rowspan="1">0.216 (0.127; 0.305)</td><td char="." align="char" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001*</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Model 2</td><td align="left" colspan="1" rowspan="1">0.414</td><td align="left" colspan="1" rowspan="1">0.193 (0.091; 0.295)</td><td char="." align="char" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001*</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Model 3</td><td align="left" colspan="1" rowspan="1">0.428</td><td align="left" colspan="1" rowspan="1">0.199 (0.095; 0.303)</td><td char="." align="char" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001*</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Model 4</td><td align="left" colspan="1" rowspan="1">0.481</td><td align="left" colspan="1" rowspan="1">0.224 (0.121; 0.328)</td><td char="." align="char" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001*</td></tr><tr><td align="left" colspan="1" rowspan="1">SCOPA-SLEEP<sup>a</sup></td><td align="left" colspan="1" rowspan="1">89</td><td align="left" colspan="1" rowspan="1">Model 1</td><td align="left" colspan="1" rowspan="1">&#8722;0.331</td><td align="left" colspan="1" rowspan="1">&#8722;0.014 (&#8722;0.022; &#8722;0.005)</td><td char="." align="char" colspan="1" rowspan="1">0.002*</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Model 2</td><td align="left" colspan="1" rowspan="1">&#8722;0.202</td><td align="left" colspan="1" rowspan="1">&#8722;0.008 (&#8722;0.018; 0.001)</td><td char="." align="char" colspan="1" rowspan="1">0.081</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Model 3</td><td align="left" colspan="1" rowspan="1">&#8722;0.202</td><td align="left" colspan="1" rowspan="1">&#8722;0.008 (&#8722;0.018; 0.001)</td><td char="." align="char" colspan="1" rowspan="1">0.087</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Model 4</td><td align="left" colspan="1" rowspan="1">&#8722;0.210</td><td align="left" colspan="1" rowspan="1">&#8722;0.009 (&#8722;0.019; 0.001)</td><td char="." align="char" colspan="1" rowspan="1">0.084</td></tr><tr><td align="left" colspan="1" rowspan="1">SCOPA-AUT</td><td align="left" colspan="1" rowspan="1">88</td><td align="left" colspan="1" rowspan="1">Model 1</td><td align="left" colspan="1" rowspan="1">&#8722;0.425</td><td align="left" colspan="1" rowspan="1">&#8722;0.421 (&#8722;0.613; &#8722;0.229)</td><td char="." align="char" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001*</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Model 2</td><td align="left" colspan="1" rowspan="1">&#8722;0.308</td><td align="left" colspan="1" rowspan="1">&#8722;0.305 (&#8722;0.516; &#8722;0.095)</td><td char="." align="char" colspan="1" rowspan="1">0.005*</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Model 3</td><td align="left" colspan="1" rowspan="1">&#8722;0.280</td><td align="left" colspan="1" rowspan="1">&#8722;0.277 (&#8722;0.491; &#8722;0.063)</td><td char="." align="char" colspan="1" rowspan="1">0.012*</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Model 4</td><td align="left" colspan="1" rowspan="1">&#8722;0.273</td><td align="left" colspan="1" rowspan="1">&#8722;0.270 (&#8722;0.491; &#8722;0.049)</td><td char="." align="char" colspan="1" rowspan="1">0.017*</td></tr><tr><td align="left" colspan="1" rowspan="1">SCOPA-PC</td><td align="left" colspan="1" rowspan="1">89</td><td align="left" colspan="1" rowspan="1">Model 1</td><td align="left" colspan="1" rowspan="1">&#8722;0.290</td><td align="left" colspan="1" rowspan="1">&#8722;0.073 (&#8722;0.124; &#8722;0.022)</td><td char="." align="char" colspan="1" rowspan="1">0.006*</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Model 2</td><td align="left" colspan="1" rowspan="1">&#8722;0.193</td><td align="left" colspan="1" rowspan="1">&#8722;0.048 (&#8722;0.106; 0.010)</td><td char="." align="char" colspan="1" rowspan="1">0.104</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Model 3</td><td align="left" colspan="1" rowspan="1">&#8722;0.196</td><td align="left" colspan="1" rowspan="1">&#8722;0.049 (&#8722;0.109; 0.011)</td><td char="." align="char" colspan="1" rowspan="1">0.106</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Model 4</td><td align="left" colspan="1" rowspan="1">&#8722;0.248</td><td align="left" colspan="1" rowspan="1">&#8722;0.062 (&#8722;0.122; &#8722;0.002)</td><td char="." align="char" colspan="1" rowspan="1">0.043*</td></tr><tr><td align="left" colspan="1" rowspan="1">BAI</td><td align="left" colspan="1" rowspan="1">89</td><td align="left" colspan="1" rowspan="1">Model 1</td><td align="left" colspan="1" rowspan="1">0.082</td><td align="left" colspan="1" rowspan="1">0.121 (&#8722;0.190; 0.432)</td><td char="." align="char" colspan="1" rowspan="1">0.442</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Model 2</td><td align="left" colspan="1" rowspan="1">0.111</td><td align="left" colspan="1" rowspan="1">0.163 (&#8722;0.193; 0.519)</td><td char="." align="char" colspan="1" rowspan="1">0.365</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Model 3</td><td align="left" colspan="1" rowspan="1">0.108</td><td align="left" colspan="1" rowspan="1">0.159 (&#8722;0.206; 0.523)</td><td char="." align="char" colspan="1" rowspan="1">0.390</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Model 4</td><td align="left" colspan="1" rowspan="1">0.115</td><td align="left" colspan="1" rowspan="1">0.168 (&#8722;0.207; 0.543)</td><td char="." align="char" colspan="1" rowspan="1">0.376</td></tr><tr><td align="left" colspan="1" rowspan="1">BDI<sup>a</sup></td><td align="left" colspan="1" rowspan="1">89</td><td align="left" colspan="1" rowspan="1">Model 1</td><td align="left" colspan="1" rowspan="1">&#8722;0.223</td><td align="left" colspan="1" rowspan="1">&#8722;0.009 (&#8722;0.017; &#8722;0.001)</td><td char="." align="char" colspan="1" rowspan="1">0.036*</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Model 2</td><td align="left" colspan="1" rowspan="1">&#8722;0.177</td><td align="left" colspan="1" rowspan="1">&#8722;0.007 (&#8722;0.016; 0.002)</td><td char="." align="char" colspan="1" rowspan="1">0.133</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Model 3</td><td align="left" colspan="1" rowspan="1">&#8722;0.190</td><td align="left" colspan="1" rowspan="1">&#8722;0.008 (&#8722;0.017; 0.002)</td><td char="." align="char" colspan="1" rowspan="1">0.116</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Model 4</td><td align="left" colspan="1" rowspan="1">&#8722;0.157</td><td align="left" colspan="1" rowspan="1">&#8722;0.006 (&#8722;0.016; 0.003)</td><td char="." align="char" colspan="1" rowspan="1">0.201</td></tr></tbody></table><table-wrap-foot><p>Model 1 for UPSIT&#174; only</p><p>Model 2: adjusted for sex and age</p><p>Model 3: as model 2 with adjustment for disease duration</p><p>Model 4: as model 3 with adjustment for time between follow-up and baseline</p><p>&#946; standardized coefficient; B unstandardized coefficient; <italic toggle="yes">CI</italic> confidence interval</p><p><sup>a</sup>Log transformed data</p><p>*Significant (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05)</p><p><italic toggle="yes">UPDRS III</italic> Unified Parkinson&#8217;s Disease Rating Scale motor subscale, <italic toggle="yes">MMSE</italic> Mini-Mental State Examination, <italic toggle="yes">SCOPA</italic> SCales for Outcomes in PArkinson&#8217;s Disease, <italic toggle="yes">AUT</italic> autonomic dysfunction, <italic toggle="yes">PC</italic> psychiatric complications, <italic toggle="yes">BAI</italic> Beck Anxiety Inventory, <italic toggle="yes">BDI</italic> Beck Depression Inventory</p></table-wrap-foot></table-wrap></p><p id="Par31">In the subgroup of patients with comprehensive cognitive testing at follow-up (<italic toggle="yes">n</italic>&#8201;=&#8201;62), an association was found between baseline olfactory function and semantic fluency at follow-up (Table&#160;<xref rid="Tab5" ref-type="table">5</xref>, Fig.&#160;<xref rid="Fig2" ref-type="fig">2</xref>). This association remained significant after Bonferroni correction.
<table-wrap id="Tab5" position="float" orientation="portrait"><label>Table&#160;5</label><caption><p>Results of the linear regression analyses relating baseline UPSIT&#174; score to comprehensive cognitive test scores at follow-up</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1"/><th align="left" colspan="1" rowspan="1"><italic toggle="yes">N</italic></th><th align="left" colspan="1" rowspan="1"/><th align="left" colspan="1" rowspan="1">&#946;</th><th align="left" colspan="1" rowspan="1"><italic toggle="yes">B</italic> (95% CI)</th><th align="left" colspan="1" rowspan="1">Sign. (<italic toggle="yes">p</italic>)</th></tr></thead><tbody><tr><td align="left" rowspan="2" colspan="1">Rey&#8217;s Auditory Verbal Learning Test &#8211; delayed recall</td><td align="left" colspan="1" rowspan="1">62</td><td align="left" colspan="1" rowspan="1">Model 1</td><td char="." align="char" colspan="1" rowspan="1">0.390</td><td align="left" colspan="1" rowspan="1">0.749 (0.292; 1.205)</td><td char="." align="char" colspan="1" rowspan="1">0.002*</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Model 2</td><td char="." align="char" colspan="1" rowspan="1">0.200</td><td align="left" colspan="1" rowspan="1">0.383 (&#8722;0.108; 0.874)</td><td char="." align="char" colspan="1" rowspan="1">0.124</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Model 3</td><td char="." align="char" colspan="1" rowspan="1">0.198</td><td align="left" colspan="1" rowspan="1">0.380 (&#8722;0.123; 0.883)</td><td char="." align="char" colspan="1" rowspan="1">0.136</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Model 4</td><td char="." align="char" colspan="1" rowspan="1">0.214</td><td align="left" colspan="1" rowspan="1">0.410 (&#8722;0.117; 0.937)</td><td char="." align="char" colspan="1" rowspan="1">0.125</td></tr><tr><td align="left" colspan="1" rowspan="1">Stroop Color-Word test</td><td align="left" colspan="1" rowspan="1">61</td><td align="left" colspan="1" rowspan="1">Model 1</td><td char="." align="char" colspan="1" rowspan="1">0.191</td><td align="left" colspan="1" rowspan="1">0.281 (&#8722;0.095; 0.657)</td><td char="." align="char" colspan="1" rowspan="1">0.141</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Model 2</td><td char="." align="char" colspan="1" rowspan="1">0.050</td><td align="left" colspan="1" rowspan="1">0.073 (&#8722;0.359; 0.505)</td><td char="." align="char" colspan="1" rowspan="1">0.737</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Model 3</td><td char="." align="char" colspan="1" rowspan="1">0.035</td><td align="left" colspan="1" rowspan="1">0.051 (&#8722;0.390; 0.493)</td><td char="." align="char" colspan="1" rowspan="1">0.817</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Model 4</td><td char="." align="char" colspan="1" rowspan="1">0.018</td><td align="left" colspan="1" rowspan="1">0.027 (&#8722;0.438; 0.492)</td><td char="." align="char" colspan="1" rowspan="1">0.908</td></tr><tr><td align="left" colspan="1" rowspan="1">Forward Digit Span</td><td align="left" colspan="1" rowspan="1">62</td><td align="left" colspan="1" rowspan="1">Model 1</td><td char="." align="char" colspan="1" rowspan="1">0.113</td><td align="left" colspan="1" rowspan="1">0.238 (&#8722;0.303; 0.778)</td><td char="." align="char" colspan="1" rowspan="1">0.382</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Model 2</td><td char="." align="char" colspan="1" rowspan="1">0.025</td><td align="left" colspan="1" rowspan="1">0.053 (&#8722;0.579; 0.686)</td><td char="." align="char" colspan="1" rowspan="1">0.867</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Model 3</td><td char="." align="char" colspan="1" rowspan="1">&#8722;0.004</td><td align="left" colspan="1" rowspan="1">&#8722;0.007 (&#8722;0.650; 0.635)</td><td char="." align="char" colspan="1" rowspan="1">0.982</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Model 4</td><td char="." align="char" colspan="1" rowspan="1">0.048</td><td align="left" colspan="1" rowspan="1">0.100 (&#8722;0.565; 0.766)</td><td char="." align="char" colspan="1" rowspan="1">0.764</td></tr><tr><td align="left" colspan="1" rowspan="1">Reverse Digit Span</td><td align="left" colspan="1" rowspan="1">62</td><td align="left" colspan="1" rowspan="1">Model 1</td><td char="." align="char" colspan="1" rowspan="1">0.284</td><td align="left" colspan="1" rowspan="1">0.479 (0.062; 0.895)</td><td char="." align="char" colspan="1" rowspan="1">0.025*</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Model 2</td><td char="." align="char" colspan="1" rowspan="1">0.120</td><td align="left" colspan="1" rowspan="1">0.202 (&#8722;0.272; 0.676)</td><td char="." align="char" colspan="1" rowspan="1">0.396</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Model 3</td><td char="." align="char" colspan="1" rowspan="1">0.087</td><td align="left" colspan="1" rowspan="1">0.146 (&#8722;0.333; 0.625)</td><td char="." align="char" colspan="1" rowspan="1">0.543</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Model 4</td><td char="." align="char" colspan="1" rowspan="1">0.134</td><td align="left" colspan="1" rowspan="1">0.226 (&#8722;0.270; 0.723)</td><td char="." align="char" colspan="1" rowspan="1">0.336</td></tr><tr><td align="left" colspan="1" rowspan="1">Phonemic fluency</td><td align="left" colspan="1" rowspan="1">62</td><td align="left" colspan="1" rowspan="1">Model 1</td><td char="." align="char" colspan="1" rowspan="1">0.302</td><td align="left" colspan="1" rowspan="1">0.524 (0.096; 0.951)</td><td char="." align="char" colspan="1" rowspan="1">0.017*</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Model 2</td><td char="." align="char" colspan="1" rowspan="1">0.277</td><td align="left" colspan="1" rowspan="1">0.481 (&#8722;0.017; 0.979)</td><td char="." align="char" colspan="1" rowspan="1">0.058</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Model 3</td><td char="." align="char" colspan="1" rowspan="1">0.236</td><td align="left" colspan="1" rowspan="1">0.410 (&#8722;0.090; 0.910)</td><td char="." align="char" colspan="1" rowspan="1">0.106</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Model 4</td><td char="." align="char" colspan="1" rowspan="1">0.341</td><td align="left" colspan="1" rowspan="1">0.593 (0.100; 1.086)</td><td char="." align="char" colspan="1" rowspan="1">0.019*</td></tr><tr><td align="left" colspan="1" rowspan="1">Semantic fluency</td><td align="left" colspan="1" rowspan="1">61</td><td align="left" colspan="1" rowspan="1">Model 1</td><td char="." align="char" colspan="1" rowspan="1">0.476</td><td align="left" colspan="1" rowspan="1">0.817 (0.427; 1.207)</td><td char="." align="char" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001*</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Model 2</td><td char="." align="char" colspan="1" rowspan="1">0.420</td><td align="left" colspan="1" rowspan="1">0.722 (0.262; 1.182)</td><td char="." align="char" colspan="1" rowspan="1">0.003*</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Model 3</td><td char="." align="char" colspan="1" rowspan="1">0.390</td><td align="left" colspan="1" rowspan="1">0.669 (0.204; 1.134)</td><td char="." align="char" colspan="1" rowspan="1">0.006*</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Model 4</td><td char="." align="char" colspan="1" rowspan="1">0.454</td><td align="left" colspan="1" rowspan="1">0.779 (0.302; 1.255)</td><td char="." align="char" colspan="1" rowspan="1">0.002*</td></tr></tbody></table><table-wrap-foot><p>Model 1 for UPSIT&#174; only</p><p>Model 2: adjusted for sex and age</p><p>Model 3: as model 2 with adjustment for disease duration</p><p>Model 4: as model 3 with adjustment for time between follow-up and baseline</p><p>&#946;: standardized coefficient; B: unstandardized coefficient; <italic toggle="yes">CI</italic> confidence interval</p><p>*Significant (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05)</p></table-wrap-foot></table-wrap><fig id="Fig2" position="float" orientation="portrait"><label>Fig.&#160;2</label><caption><p>Scatterplot showing the relation between baseline UPSIT&#174; score and semantic fluency at follow-up</p></caption><graphic id="MO2" position="float" orientation="portrait" xlink:href="415_2025_13337_Fig2_HTML.jpg"/></fig></p></sec></sec><sec id="Sec14"><title>Discussion</title><p id="Par32">In this ten-year longitudinal cohort study in PD patients, worsening olfactory function was associated with a decline in global cognitive functioning, as measured with the MMSE, and not with changes in any of the other motor and other non-motor symptoms measured. Comprehensive cognitive testing in a subset of patients revealed that worsening olfactory function was specifically associated with a decrease in semantic fluency, but not in phonemic fluency or other cognitive functions. A post hoc analysis did not show that other clinical measures could explain these observed correlations (data not shown). Furthermore, lower baseline olfactory test score was associated with worse global cognitive functioning, more specifically semantic fluency, after ten years follow-up.</p><p id="Par33">The results of the present longitudinal study confirm the observation in our earlier cross-sectional study of a correlation between olfactory function and global cognitive function. However, in our cross-sectional study we observed additional correlations between olfactory function and both motor and non-motor symptoms (depression, anxiety, autonomic dysfunction, and sleep disturbances) [<xref ref-type="bibr" rid="CR24">24</xref>]. Cross-sectional data limit the ability to establish causality or assess time-related effects. On the other hand, participant dropouts might have influenced our longitudinal results, potentially explaining why we were unable to replicate all previous cross-sectional findings.</p><p id="Par34">Our present observation that olfactory function is unrelated to motor symptom severity aligns with previous longitudinal studies [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR50">50</xref>]. However, this contrasts with the study by He et al., which reported worse motor symptoms in hyposmic compared to normosmic PD patients [<xref ref-type="bibr" rid="CR27">27</xref>]. One possible explanation for this discrepancy is the difference in follow-up duration. The relatively short follow-up in He et al.&#8217;s study may have led to an overestimation of the association, as early differences between hyposmic and normosmic patients could diminish over time.</p><p id="Par35">To date, little research has been conducted on the relationship between olfaction and cognitive functioning in PD patients. Our results confirm the observation in the longitudinal study by He et al. that hyposmic PD patients had lower MMSE scores at baseline, indicating worse cognitive functioning, compared to normosmic PD patients [<xref ref-type="bibr" rid="CR27">27</xref>]. The results of our study are also in line with previous data that focused on the prediction of cognitive decline using baseline olfactory testing. For example, one study showed that baseline olfactory function was related to change in cognitive functioning over time [<xref ref-type="bibr" rid="CR29">29</xref>]. In another study olfactory dysfunction at baseline increased the subsequent risk of dementia in PD over a long period of time (median six years) [<xref ref-type="bibr" rid="CR30">30</xref>].</p><p id="Par36">In the subgroup of patients in which we performed comprehensive cognitive testing, we found that worsening of olfactory function was associated with a decrease in semantic fluency, but not in phonemic fluency. Successful performance in both semantic and phonemic fluency requires executive control to constantly monitor words in a specific category already named or letters already processed, as well to switch between letters [<xref ref-type="bibr" rid="CR51">51</xref>]. While there is shared variance between performance on semantic and phonemic fluency tasks, these measures do capture distinct cognitive processes [<xref ref-type="bibr" rid="CR52">52</xref>]. These distinct cognitive processes are expressed as a neural dissociation, with semantic fluency deficits more often occurring after damage to the left temporal regions [<xref ref-type="bibr" rid="CR53">53</xref>&#8211;<xref ref-type="bibr" rid="CR55">55</xref>], and phonemic fluency deficits more often seen after damage to the frontal regions [<xref ref-type="bibr" rid="CR53">53</xref>, <xref ref-type="bibr" rid="CR55">55</xref>&#8211;<xref ref-type="bibr" rid="CR57">57</xref>]. There is no consistent evidence on the role of white matter tracts in each fluency measure. An earlier longitudinal cohort study found that a decline in semantic fluency, not phonemic fluency, was predictive of later cognitive decline in PD [<xref ref-type="bibr" rid="CR58">58</xref>]. The authors suggested that this reflects a more posterior and cortical degenerative process in PD associated with deficits in semantic fluency and likely driven by a non-dopaminergic etiology. Given the observed link between worsening olfactory function and semantic fluency decline, our findings may suggest that olfactory dysfunction in PD is indicative of neurodegenerative processes affecting temporal regions rather than frontal areas.</p><p id="Par37">Olfactory dysfunction in PD is thought to result from &#945;-synuclein pathology affecting both the olfactory bulb and central olfactory processing areas, including the piriform cortex, amygdala, and orbitofrontal cortex. Additionally, disruptions in specific neurotransmitter systems, particularly cholinergic pathways, may further contribute to, or even precede, olfactory impairment [<xref ref-type="bibr" rid="CR59">59</xref>]. Given that cognitive decline in PD is linked to neurodegeneration in overlapping brain regions, such as orbitofrontal cortex and temporal lobe, these shared mechanisms could explain the observed association between olfactory and cognitive impairment. Furthermore, the ongoing decline in olfactory function may reflect the spread of disease-specific pathology to cortical brain regions as the disease progresses, in addition to previously recognized changes in the olfactory bulb [<xref ref-type="bibr" rid="CR32">32</xref>].</p><p id="Par38">The fact that baseline olfactory function is associated with later cognitive functioning in the present and previous studies [<xref ref-type="bibr" rid="CR29">29</xref>&#8211;<xref ref-type="bibr" rid="CR31">31</xref>], suggests that testing olfaction in an early stage of disease may help predict imminent cognitive decline. From that perspective, it is a major advantage that olfactory tests are easy to administer, non-invasive, and unaffected by the use of dopaminergic medication or motor functioning. While not a standalone diagnostic tool, olfactory testing may contribute to identifying patients at higher risk for cognitive decline in PD when used alongside other biomarkers, as has been done for Alzheimer&#8217;s disease [<xref ref-type="bibr" rid="CR60">60</xref>]. Obviously, this hypothesis should be addressed in larger patient populations using a prospective longitudinal study design and multimodal testing.</p><p id="Par39">An important strength of our study is the length of the follow-up period, averaging ten years. This extended duration allowed us to track the progression of olfactory and cognitive decline over the course of many years, providing valuable insights into their longitudinal relationship in PD. Moreover, it enabled the identification of long-term patterns that may not be detectable in shorter studies, strengthening the reliability of our findings on disease progression. Additionally, both baseline and follow-up assessments were carried out by a single neurologist specialized in movement disorders (DR). This consistency reduces the risk of interrater variability and helps ensure that participants met clinical criteria for PD throughout the study. Another strength of our study is the use of a well-validated self-administered odor identification test that has been widely employed in PD research [<xref ref-type="bibr" rid="CR59">59</xref>, <xref ref-type="bibr" rid="CR61">61</xref>]. This highly reliable test (test&#8211;retest <italic toggle="yes">r</italic>&#8201;=&#8201;0.92) correlates well with other types of olfactory tests, most notably odor detection threshold tests (e.g., Spearman <italic toggle="yes">r</italic>&#8201;=&#8201;0.65 in a study of 733 subjects) [<xref ref-type="bibr" rid="CR62">62</xref>]. However, unlike threshold tests, self-administered tests such as the UPSIT&#174; preclude potential examiner influences on the test measure.</p><p id="Par40">Our study has several limitations. First, since some patients declined participation in the comprehensive cognitive testing due to its burdensomeness, a sampling bias may have occurred. Thus, many patients who did not participate in this testing had lower MMSE scores. As a result, the correlation we found with semantic fluency could have been attenuated and the detection of other potential correlations missed. Second, our cohort was relatively young at baseline, which may partially explain the modest cognitive decline observed over ten years. Third, to reduce the total duration of study visits, we conducted a limited neuropsychological assessment, using a single test per cognitive domain. Since the official criteria for diagnosing mild cognitive impairment (MCI) and PD dementia (PDD) recommend at least two tests per domain, our approach may have underestimated cognitive impairment and its associations with other variables [<xref ref-type="bibr" rid="CR63">63</xref>, <xref ref-type="bibr" rid="CR64">64</xref>]. Fourth, since the UPSIT&#174; was completed unsupervised at baseline, olfactory function may have been underestimated at that time. As a result, the actual decline in olfactory function over ten years may have been larger than what we measured. This, in turn, suggests that the observed relationship between olfactory function and cognition, particularly semantic fluency, might also have been stronger than reported, although, in general, self-administration of the UPSIT&#174; does not differ from proctored administration [<xref ref-type="bibr" rid="CR65">65</xref>]. Finally, it would have been of interest to also have measured thresholds in addition to odor identification test scores to better define the relationship between olfaction and semantic fluency.</p><p id="Par41">In conclusion, we found that over a ten-year period the decline in olfactory function in PD was associated with worsening cognitive function, particularly semantic fluency. While olfactory testing alone most likely is not sufficient for predicting cognitive decline, our observations suggest that it may help identify patients at an increased risk when used alongside other biomarkers. This could be particularly relevant in research settings or for refining patient stratification in future clinical trials.</p></sec><sec id="Sec15" sec-type="supplementary-material"><title>Supplementary Information</title><p>Below is the link to the electronic supplementary material.<supplementary-material content-type="local-data" id="MOESM1" position="float" orientation="portrait"><media xlink:href="415_2025_13337_MOESM1_ESM.docx" position="float" orientation="portrait"><caption><p>Supplementary file1 (DOCX 36 KB)</p></caption></media></supplementary-material></p></sec></body><back><notes notes-type="author-contribution"><title>Author contributions</title><p>DS Roos: design, execution, analysis, writing, editing of final version, HW Berendse: design, analysis, writing, editing of final version, RL Doty: writing, editing of final version, JWR Twisk: analysis, editing of final version, M Klein: design, analysis, writing, editing of final version.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>This project was funded by the Dutch Parkinson Foundation (2020-R-10). The funder had no involvement in the study design; the collection, analysis, and interpretation of the data; writing the manuscript; and in decision to submit the paper for publication.</p></notes><notes notes-type="data-availability"><title>Data availability</title><p>The datasets from this clinical research are available from the corresponding author upon reasonable request.</p></notes><notes><title>Declarations</title><notes id="FPar1" notes-type="COI-statement"><title>Conflicts of interest</title><p id="Par42">HW Berendse received funding from the Dutch Parkinson Foundation (2020-R-10) for this project. RL Doty is the President of, and a major shareholder in, Sensonics International, the manufacturer and distributor of smell and taste tests, including the test employed in this study.</p></notes><notes id="FPar2"><title>Ethical standard</title><p>The study was approved by the Medical Ethical Committee of Amsterdam UMC, location Vrije Universiteit Amsterdam (VUmc; 2020.012). All patients gave written informed consent.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Doty</surname><given-names>RL</given-names></name><name name-style="western"><surname>Deems</surname><given-names>DA</given-names></name><name name-style="western"><surname>Stellar</surname><given-names>S</given-names></name></person-group><article-title>Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease duration</article-title><source>Neurology</source><year>1988</year><volume>38</volume><fpage>1237</fpage><lpage>1244</lpage><pub-id pub-id-type="pmid">3399075</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1212/wnl.38.8.1237</pub-id></element-citation><mixed-citation id="mc-CR1" publication-type="journal">Doty RL, Deems DA, Stellar S (1988) Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease duration. Neurology 38:1237&#8211;1244<pub-id pub-id-type="pmid">3399075</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1212/wnl.38.8.1237</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hawkes</surname><given-names>CH</given-names></name><name name-style="western"><surname>Shephard</surname><given-names>BC</given-names></name><name name-style="western"><surname>Daniel</surname><given-names>SE</given-names></name></person-group><article-title>Olfactory dysfunction in Parkinson's disease</article-title><source>J Neurol Neurosurg Psychiatry</source><year>1997</year><volume>62</volume><fpage>436</fpage><lpage>446</lpage><pub-id pub-id-type="pmid">9153598</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/jnnp.62.5.436</pub-id><pub-id pub-id-type="pmcid">PMC486843</pub-id></element-citation><mixed-citation id="mc-CR2" publication-type="journal">Hawkes CH, Shephard BC, Daniel SE (1997) Olfactory dysfunction in Parkinson&#8217;s disease. J Neurol Neurosurg Psychiatry 62:436&#8211;446<pub-id pub-id-type="pmid">9153598</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/jnnp.62.5.436</pub-id><pub-id pub-id-type="pmcid">PMC486843</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Haehner</surname><given-names>A</given-names></name><name name-style="western"><surname>Boesveldt</surname><given-names>S</given-names></name><name name-style="western"><surname>Berendse</surname><given-names>HW</given-names></name><name name-style="western"><surname>Mackay-Sim</surname><given-names>A</given-names></name><name name-style="western"><surname>Fleischmann</surname><given-names>J</given-names></name><name name-style="western"><surname>Silburn</surname><given-names>PA</given-names></name><name name-style="western"><surname>Johnston</surname><given-names>AN</given-names></name><name name-style="western"><surname>Mellick</surname><given-names>GD</given-names></name><name name-style="western"><surname>Herting</surname><given-names>B</given-names></name><name name-style="western"><surname>Reichmann</surname><given-names>H</given-names></name><name name-style="western"><surname>Hummel</surname><given-names>T</given-names></name></person-group><article-title>Prevalence of smell loss in Parkinson's disease&#8211;a multicenter study</article-title><source>Parkinsonism Relat Disord</source><year>2009</year><volume>15</volume><fpage>490</fpage><lpage>494</lpage><pub-id pub-id-type="pmid">19138875</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.parkreldis.2008.12.005</pub-id></element-citation><mixed-citation id="mc-CR3" publication-type="journal">Haehner A, Boesveldt S, Berendse HW, Mackay-Sim A, Fleischmann J, Silburn PA, Johnston AN, Mellick GD, Herting B, Reichmann H, Hummel T (2009) Prevalence of smell loss in Parkinson&#8217;s disease&#8211;a multicenter study. Parkinsonism Relat Disord 15:490&#8211;494<pub-id pub-id-type="pmid">19138875</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.parkreldis.2008.12.005</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ponsen</surname><given-names>MM</given-names></name><name name-style="western"><surname>Stoffers</surname><given-names>D</given-names></name><name name-style="western"><surname>Booij</surname><given-names>J</given-names></name><name name-style="western"><surname>van Eck-Smit</surname><given-names>BL</given-names></name><name name-style="western"><surname>Wolters</surname><given-names>E</given-names></name><name name-style="western"><surname>Berendse</surname><given-names>HW</given-names></name></person-group><article-title>Idiopathic hyposmia as a preclinical sign of Parkinson's disease</article-title><source>Ann Neurol</source><year>2004</year><volume>56</volume><fpage>173</fpage><lpage>181</lpage><pub-id pub-id-type="pmid">15293269</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/ana.20160</pub-id></element-citation><mixed-citation id="mc-CR4" publication-type="journal">Ponsen MM, Stoffers D, Booij J, van Eck-Smit BL, Wolters E, Berendse HW (2004) Idiopathic hyposmia as a preclinical sign of Parkinson&#8217;s disease. Ann Neurol 56:173&#8211;181<pub-id pub-id-type="pmid">15293269</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/ana.20160</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ross</surname><given-names>GW</given-names></name><name name-style="western"><surname>Petrovitch</surname><given-names>H</given-names></name><name name-style="western"><surname>Abbott</surname><given-names>RD</given-names></name><name name-style="western"><surname>Tanner</surname><given-names>CM</given-names></name><name name-style="western"><surname>Popper</surname><given-names>J</given-names></name><name name-style="western"><surname>Masaki</surname><given-names>K</given-names></name><name name-style="western"><surname>Launer</surname><given-names>L</given-names></name><name name-style="western"><surname>White</surname><given-names>LR</given-names></name></person-group><article-title>Association of olfactory dysfunction with risk for future Parkinson's disease</article-title><source>Ann Neurol</source><year>2008</year><volume>63</volume><fpage>167</fpage><lpage>173</lpage><pub-id pub-id-type="pmid">18067173</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/ana.21291</pub-id></element-citation><mixed-citation id="mc-CR5" publication-type="journal">Ross GW, Petrovitch H, Abbott RD, Tanner CM, Popper J, Masaki K, Launer L, White LR (2008) Association of olfactory dysfunction with risk for future Parkinson&#8217;s disease. Ann Neurol 63:167&#8211;173<pub-id pub-id-type="pmid">18067173</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/ana.21291</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cavaco</surname><given-names>S</given-names></name><name name-style="western"><surname>Goncalves</surname><given-names>A</given-names></name><name name-style="western"><surname>Mendes</surname><given-names>A</given-names></name><name name-style="western"><surname>Vila-Cha</surname><given-names>N</given-names></name><name name-style="western"><surname>Moreira</surname><given-names>I</given-names></name><name name-style="western"><surname>Fernandes</surname><given-names>J</given-names></name><name name-style="western"><surname>Damasio</surname><given-names>J</given-names></name><name name-style="western"><surname>Teixeira-Pinto</surname><given-names>A</given-names></name><name name-style="western"><surname>Bastos Lima</surname><given-names>A</given-names></name></person-group><article-title>Abnormal olfaction in Parkinson's disease is related to faster disease progression</article-title><source>Behav Neurol</source><year>2015</year><volume>2015</volume><fpage>976589</fpage><pub-id pub-id-type="pmid">26136625</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1155/2015/976589</pub-id><pub-id pub-id-type="pmcid">PMC4468273</pub-id></element-citation><mixed-citation id="mc-CR6" publication-type="journal">Cavaco S, Goncalves A, Mendes A, Vila-Cha N, Moreira I, Fernandes J, Damasio J, Teixeira-Pinto A, Bastos Lima A (2015) Abnormal olfaction in Parkinson&#8217;s disease is related to faster disease progression. Behav Neurol 2015:976589<pub-id pub-id-type="pmid">26136625</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1155/2015/976589</pub-id><pub-id pub-id-type="pmcid">PMC4468273</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Deeb</surname><given-names>J</given-names></name><name name-style="western"><surname>Shah</surname><given-names>M</given-names></name><name name-style="western"><surname>Muhammed</surname><given-names>N</given-names></name><name name-style="western"><surname>Gunasekera</surname><given-names>R</given-names></name><name name-style="western"><surname>Gannon</surname><given-names>K</given-names></name><name name-style="western"><surname>Findley</surname><given-names>LJ</given-names></name><name name-style="western"><surname>Hawkes</surname><given-names>CH</given-names></name></person-group><article-title>A basic smell test is as sensitive as a dopamine transporter scan: comparison of olfaction, taste and DaTSCAN in the diagnosis of Parkinson's disease</article-title><source>QJM</source><year>2010</year><volume>103</volume><fpage>941</fpage><lpage>952</lpage><pub-id pub-id-type="pmid">20736182</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/qjmed/hcq142</pub-id></element-citation><mixed-citation id="mc-CR7" publication-type="journal">Deeb J, Shah M, Muhammed N, Gunasekera R, Gannon K, Findley LJ, Hawkes CH (2010) A basic smell test is as sensitive as a dopamine transporter scan: comparison of olfaction, taste and DaTSCAN in the diagnosis of Parkinson&#8217;s disease. QJM 103:941&#8211;952<pub-id pub-id-type="pmid">20736182</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/qjmed/hcq142</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>DH</given-names></name><name name-style="western"><surname>Oh</surname><given-names>JS</given-names></name><name name-style="western"><surname>Ham</surname><given-names>JH</given-names></name><name name-style="western"><surname>Lee</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Lee</surname><given-names>I</given-names></name><name name-style="western"><surname>Lee</surname><given-names>PH</given-names></name><name name-style="western"><surname>Kim</surname><given-names>JS</given-names></name><name name-style="western"><surname>Sohn</surname><given-names>YH</given-names></name></person-group><article-title>Is normosmic Parkinson disease a unique clinical phenotype?</article-title><source>Neurology</source><year>2015</year><volume>85</volume><fpage>1270</fpage><lpage>1275</lpage><pub-id pub-id-type="pmid">26354986</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1212/WNL.0000000000001999</pub-id></element-citation><mixed-citation id="mc-CR8" publication-type="journal">Lee DH, Oh JS, Ham JH, Lee JJ, Lee I, Lee PH, Kim JS, Sohn YH (2015) Is normosmic Parkinson disease a unique clinical phenotype? Neurology 85:1270&#8211;1275<pub-id pub-id-type="pmid">26354986</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1212/WNL.0000000000001999</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Masala</surname><given-names>C</given-names></name><name name-style="western"><surname>Solla</surname><given-names>P</given-names></name><name name-style="western"><surname>Liscia</surname><given-names>A</given-names></name><name name-style="western"><surname>Defazio</surname><given-names>G</given-names></name><name name-style="western"><surname>Saba</surname><given-names>L</given-names></name><name name-style="western"><surname>Cannas</surname><given-names>A</given-names></name><name name-style="western"><surname>Cavazzana</surname><given-names>A</given-names></name><name name-style="western"><surname>Hummel</surname><given-names>T</given-names></name><name name-style="western"><surname>Haehner</surname><given-names>A</given-names></name></person-group><article-title>Correlation among olfactory function, motors' symptoms, cognitive impairment, apathy, and fatigue in patients with Parkinson's disease</article-title><source>J Neurol</source><year>2018</year><pub-id pub-id-type="pmid">29804147</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00415-018-8913-9</pub-id></element-citation><mixed-citation id="mc-CR9" publication-type="journal">Masala C, Solla P, Liscia A, Defazio G, Saba L, Cannas A, Cavazzana A, Hummel T, Haehner A (2018) Correlation among olfactory function, motors&#8217; symptoms, cognitive impairment, apathy, and fatigue in patients with Parkinson&#8217;s disease. J Neurol. 10.1007/s00415-018-8913-9<pub-id pub-id-type="pmid">29804147</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00415-018-8913-9</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tissingh</surname><given-names>G</given-names></name><name name-style="western"><surname>Berendse</surname><given-names>HW</given-names></name><name name-style="western"><surname>Bergmans</surname><given-names>P</given-names></name><name name-style="western"><surname>DeWaard</surname><given-names>R</given-names></name><name name-style="western"><surname>Drukarch</surname><given-names>B</given-names></name><name name-style="western"><surname>Stoof</surname><given-names>JC</given-names></name><name name-style="western"><surname>Wolters</surname><given-names>EC</given-names></name></person-group><article-title>Loss of olfaction in de novo and treated Parkinson's disease: possible implications for early diagnosis</article-title><source>Mov Disord</source><year>2001</year><volume>16</volume><fpage>41</fpage><lpage>46</lpage><pub-id pub-id-type="pmid">11215591</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/1531-8257(200101)16:1&lt;41::aid-mds1017&gt;3.0.co;2-m</pub-id></element-citation><mixed-citation id="mc-CR10" publication-type="journal">Tissingh G, Berendse HW, Bergmans P, DeWaard R, Drukarch B, Stoof JC, Wolters EC (2001) Loss of olfaction in de novo and treated Parkinson&#8217;s disease: possible implications for early diagnosis. Mov Disord 16:41&#8211;46<pub-id pub-id-type="pmid">11215591</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/1531-8257(200101)16:1&lt;41::aid-mds1017&gt;3.0.co;2-m</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Boesveldt</surname><given-names>S</given-names></name><name name-style="western"><surname>Verbaan</surname><given-names>D</given-names></name><name name-style="western"><surname>Knol</surname><given-names>DL</given-names></name><name name-style="western"><surname>Visser</surname><given-names>M</given-names></name><name name-style="western"><surname>van Rooden</surname><given-names>SM</given-names></name><name name-style="western"><surname>van Hilten</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Berendse</surname><given-names>HW</given-names></name></person-group><article-title>A comparative study of odor identification and odor discrimination deficits in Parkinson's disease</article-title><source>Mov Disord</source><year>2008</year><volume>23</volume><fpage>1984</fpage><lpage>1990</lpage><pub-id pub-id-type="pmid">18759360</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/mds.22155</pub-id></element-citation><mixed-citation id="mc-CR11" publication-type="journal">Boesveldt S, Verbaan D, Knol DL, Visser M, van Rooden SM, van Hilten JJ, Berendse HW (2008) A comparative study of odor identification and odor discrimination deficits in Parkinson&#8217;s disease. Mov Disord 23:1984&#8211;1990<pub-id pub-id-type="pmid">18759360</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/mds.22155</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ramjit</surname><given-names>AL</given-names></name><name name-style="western"><surname>Sedig</surname><given-names>L</given-names></name><name name-style="western"><surname>Leibner</surname><given-names>J</given-names></name><name name-style="western"><surname>Wu</surname><given-names>SS</given-names></name><name name-style="western"><surname>Dai</surname><given-names>Y</given-names></name><name name-style="western"><surname>Okun</surname><given-names>MS</given-names></name><name name-style="western"><surname>Rodriguez</surname><given-names>RL</given-names></name><name name-style="western"><surname>Malaty</surname><given-names>IA</given-names></name><name name-style="western"><surname>Fernandez</surname><given-names>HH</given-names></name></person-group><article-title>The relationship between anosmia, constipation, and orthostasis and Parkinson's disease duration: results of a pilot study</article-title><source>Int J Neurosci</source><year>2010</year><volume>120</volume><fpage>67</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">20128674</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3109/00207450903337721</pub-id></element-citation><mixed-citation id="mc-CR12" publication-type="journal">Ramjit AL, Sedig L, Leibner J, Wu SS, Dai Y, Okun MS, Rodriguez RL, Malaty IA, Fernandez HH (2010) The relationship between anosmia, constipation, and orthostasis and Parkinson&#8217;s disease duration: results of a pilot study. Int J Neurosci 120:67&#8211;70<pub-id pub-id-type="pmid">20128674</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3109/00207450903337721</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Siderowf</surname><given-names>A</given-names></name><name name-style="western"><surname>Newberg</surname><given-names>A</given-names></name><name name-style="western"><surname>Chou</surname><given-names>KL</given-names></name><name name-style="western"><surname>Lloyd</surname><given-names>M</given-names></name><name name-style="western"><surname>Colcher</surname><given-names>A</given-names></name><name name-style="western"><surname>Hurtig</surname><given-names>HI</given-names></name><name name-style="western"><surname>Stern</surname><given-names>MB</given-names></name><name name-style="western"><surname>Doty</surname><given-names>RL</given-names></name><name name-style="western"><surname>Mozley</surname><given-names>PD</given-names></name><name name-style="western"><surname>Wintering</surname><given-names>N</given-names></name><name name-style="western"><surname>Duda</surname><given-names>JE</given-names></name><name name-style="western"><surname>Weintraub</surname><given-names>D</given-names></name><name name-style="western"><surname>Moberg</surname><given-names>PJ</given-names></name></person-group><article-title>[99mTc]TRODAT-1 SPECT imaging correlates with odor identification in early Parkinson disease</article-title><source>Neurology</source><year>2005</year><volume>64</volume><fpage>1716</fpage><lpage>1720</lpage><pub-id pub-id-type="pmid">15911797</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1212/01.WNL.0000161874.52302.5D</pub-id></element-citation><mixed-citation id="mc-CR13" publication-type="journal">Siderowf A, Newberg A, Chou KL, Lloyd M, Colcher A, Hurtig HI, Stern MB, Doty RL, Mozley PD, Wintering N, Duda JE, Weintraub D, Moberg PJ (2005) [99mTc]TRODAT-1 SPECT imaging correlates with odor identification in early Parkinson disease. Neurology 64:1716&#8211;1720<pub-id pub-id-type="pmid">15911797</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1212/01.WNL.0000161874.52302.5D</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Morley</surname><given-names>JF</given-names></name><name name-style="western"><surname>Weintraub</surname><given-names>D</given-names></name><name name-style="western"><surname>Mamikonyan</surname><given-names>E</given-names></name><name name-style="western"><surname>Moberg</surname><given-names>PJ</given-names></name><name name-style="western"><surname>Siderowf</surname><given-names>AD</given-names></name><name name-style="western"><surname>Duda</surname><given-names>JE</given-names></name></person-group><article-title>Olfactory dysfunction is associated with neuropsychiatric manifestations in Parkinson's disease</article-title><source>Mov Disord</source><year>2011</year><volume>26</volume><fpage>2051</fpage><lpage>2057</lpage><pub-id pub-id-type="pmid">21611985</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/mds.23792</pub-id><pub-id pub-id-type="pmcid">PMC3168697</pub-id></element-citation><mixed-citation id="mc-CR14" publication-type="journal">Morley JF, Weintraub D, Mamikonyan E, Moberg PJ, Siderowf AD, Duda JE (2011) Olfactory dysfunction is associated with neuropsychiatric manifestations in Parkinson&#8217;s disease. Mov Disord 26:2051&#8211;2057<pub-id pub-id-type="pmid">21611985</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/mds.23792</pub-id><pub-id pub-id-type="pmcid">PMC3168697</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Verbaan</surname><given-names>D</given-names></name><name name-style="western"><surname>Boesveldt</surname><given-names>S</given-names></name><name name-style="western"><surname>van Rooden</surname><given-names>SM</given-names></name><name name-style="western"><surname>Visser</surname><given-names>M</given-names></name><name name-style="western"><surname>Marinus</surname><given-names>J</given-names></name><name name-style="western"><surname>Macedo</surname><given-names>MG</given-names></name><name name-style="western"><surname>Fang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Heutink</surname><given-names>P</given-names></name><name name-style="western"><surname>Berendse</surname><given-names>HW</given-names></name><name name-style="western"><surname>van Hilten</surname><given-names>JJ</given-names></name></person-group><article-title>Is olfactory impairment in Parkinson disease related to phenotypic or genotypic characteristics?</article-title><source>Neurology</source><year>2008</year><volume>71</volume><fpage>1877</fpage><lpage>1882</lpage><pub-id pub-id-type="pmid">19047559</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1212/01.wnl.0000336651.48596.c7</pub-id></element-citation><mixed-citation id="mc-CR15" publication-type="journal">Verbaan D, Boesveldt S, van Rooden SM, Visser M, Marinus J, Macedo MG, Fang Y, Heutink P, Berendse HW, van Hilten JJ (2008) Is olfactory impairment in Parkinson disease related to phenotypic or genotypic characteristics? Neurology 71:1877&#8211;1882<pub-id pub-id-type="pmid">19047559</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1212/01.wnl.0000336651.48596.c7</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rossi</surname><given-names>M</given-names></name><name name-style="western"><surname>Perez-Lloret</surname><given-names>S</given-names></name><name name-style="western"><surname>Millar Vernetti</surname><given-names>P</given-names></name><name name-style="western"><surname>Drucaroff</surname><given-names>L</given-names></name><name name-style="western"><surname>Costanzo</surname><given-names>E</given-names></name><name name-style="western"><surname>Ballesteros</surname><given-names>D</given-names></name><name name-style="western"><surname>Bril</surname><given-names>A</given-names></name><name name-style="western"><surname>Cerquetti</surname><given-names>D</given-names></name><name name-style="western"><surname>Guinjoan</surname><given-names>S</given-names></name><name name-style="western"><surname>Merello</surname><given-names>M</given-names></name></person-group><article-title>Olfactory dysfunction evaluation is not affected by comorbid depression in Parkinson's disease</article-title><source>Mov Disord</source><year>2015</year><volume>30</volume><fpage>1275</fpage><lpage>1279</lpage><pub-id pub-id-type="pmid">26096632</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/mds.26276</pub-id></element-citation><mixed-citation id="mc-CR16" publication-type="journal">Rossi M, Perez-Lloret S, Millar Vernetti P, Drucaroff L, Costanzo E, Ballesteros D, Bril A, Cerquetti D, Guinjoan S, Merello M (2015) Olfactory dysfunction evaluation is not affected by comorbid depression in Parkinson&#8217;s disease. Mov Disord 30:1275&#8211;1279<pub-id pub-id-type="pmid">26096632</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/mds.26276</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>W</given-names></name><name name-style="western"><surname>Kang</surname><given-names>WY</given-names></name><name name-style="western"><surname>Chen</surname><given-names>S</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>Q</given-names></name><name name-style="western"><surname>Wang</surname><given-names>G</given-names></name><name name-style="western"><surname>Liu</surname><given-names>J</given-names></name><name name-style="western"><surname>Chen</surname><given-names>SD</given-names></name></person-group><article-title>Hyposmia correlates with SNCA variant and non-motor symptoms in Chinese patients with Parkinson's disease</article-title><source>Parkinsonism Relat Disord</source><year>2015</year><volume>21</volume><fpage>610</fpage><lpage>614</lpage><pub-id pub-id-type="pmid">25921825</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.parkreldis.2015.03.021</pub-id></element-citation><mixed-citation id="mc-CR17" publication-type="journal">Chen W, Kang WY, Chen S, Wang Y, Xiao Q, Wang G, Liu J, Chen SD (2015) Hyposmia correlates with SNCA variant and non-motor symptoms in Chinese patients with Parkinson&#8217;s disease. Parkinsonism Relat Disord 21:610&#8211;614<pub-id pub-id-type="pmid">25921825</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.parkreldis.2015.03.021</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cramer</surname><given-names>CK</given-names></name><name name-style="western"><surname>Friedman</surname><given-names>JH</given-names></name><name name-style="western"><surname>Amick</surname><given-names>MM</given-names></name></person-group><article-title>Olfaction and apathy in Parkinson's disease</article-title><source>Parkinsonism Relat Disord</source><year>2010</year><volume>16</volume><fpage>124</fpage><lpage>126</lpage><pub-id pub-id-type="pmid">19783195</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.parkreldis.2009.09.004</pub-id></element-citation><mixed-citation id="mc-CR18" publication-type="journal">Cramer CK, Friedman JH, Amick MM (2010) Olfaction and apathy in Parkinson&#8217;s disease. Parkinsonism Relat Disord 16:124&#8211;126<pub-id pub-id-type="pmid">19783195</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.parkreldis.2009.09.004</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hong</surname><given-names>JY</given-names></name><name name-style="western"><surname>Sunwoo</surname><given-names>MK</given-names></name><name name-style="western"><surname>Ham</surname><given-names>JH</given-names></name><name name-style="western"><surname>Lee</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Lee</surname><given-names>PH</given-names></name><name name-style="western"><surname>Sohn</surname><given-names>YH</given-names></name></person-group><article-title>Apathy and olfactory dysfunction in early Parkinson's disease</article-title><source>J Mov Disord</source><year>2015</year><volume>8</volume><fpage>21</fpage><lpage>25</lpage><pub-id pub-id-type="pmid">25614782</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.14802/jmd.14029</pub-id><pub-id pub-id-type="pmcid">PMC4298715</pub-id></element-citation><mixed-citation id="mc-CR19" publication-type="journal">Hong JY, Sunwoo MK, Ham JH, Lee JJ, Lee PH, Sohn YH (2015) Apathy and olfactory dysfunction in early Parkinson&#8217;s disease. J Mov Disord 8:21&#8211;25<pub-id pub-id-type="pmid">25614782</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.14802/jmd.14029</pub-id><pub-id pub-id-type="pmcid">PMC4298715</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Goldstein</surname><given-names>DS</given-names></name><name name-style="western"><surname>Sewell</surname><given-names>L</given-names></name><name name-style="western"><surname>Holmes</surname><given-names>C</given-names></name></person-group><article-title>Association of anosmia with autonomic failure in Parkinson disease</article-title><source>Neurology</source><year>2010</year><volume>74</volume><fpage>245</fpage><lpage>251</lpage><pub-id pub-id-type="pmid">20083801</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1212/WNL.0b013e3181ca014c</pub-id><pub-id pub-id-type="pmcid">PMC2809034</pub-id></element-citation><mixed-citation id="mc-CR20" publication-type="journal">Goldstein DS, Sewell L, Holmes C (2010) Association of anosmia with autonomic failure in Parkinson disease. Neurology 74:245&#8211;251<pub-id pub-id-type="pmid">20083801</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1212/WNL.0b013e3181ca014c</pub-id><pub-id pub-id-type="pmcid">PMC2809034</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Camargo</surname><given-names>CHF</given-names></name><name name-style="western"><surname>Jobbins</surname><given-names>VA</given-names></name><name name-style="western"><surname>Serpa</surname><given-names>RA</given-names></name><name name-style="western"><surname>Berbetz</surname><given-names>FA</given-names></name><name name-style="western"><surname>Sabatini</surname><given-names>JS</given-names></name><name name-style="western"><surname>Teive</surname><given-names>HAG</given-names></name></person-group><article-title>Association between olfactory loss and cognitive deficits in Parkinson's disease</article-title><source>Clin Neurol Neurosurg</source><year>2018</year><volume>173</volume><fpage>120</fpage><lpage>123</lpage><pub-id pub-id-type="pmid">30121454</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.clineuro.2018.08.018</pub-id></element-citation><mixed-citation id="mc-CR21" publication-type="journal">Camargo CHF, Jobbins VA, Serpa RA, Berbetz FA, Sabatini JS, Teive HAG (2018) Association between olfactory loss and cognitive deficits in Parkinson&#8217;s disease. Clin Neurol Neurosurg 173:120&#8211;123<pub-id pub-id-type="pmid">30121454</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.clineuro.2018.08.018</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Solla</surname><given-names>P</given-names></name><name name-style="western"><surname>Masala</surname><given-names>C</given-names></name><name name-style="western"><surname>Ercoli</surname><given-names>T</given-names></name><name name-style="western"><surname>Frau</surname><given-names>C</given-names></name><name name-style="western"><surname>Bagella</surname><given-names>C</given-names></name><name name-style="western"><surname>Pinna</surname><given-names>I</given-names></name><name name-style="western"><surname>Loy</surname><given-names>F</given-names></name><name name-style="western"><surname>Defazio</surname><given-names>G</given-names></name></person-group><article-title>Olfactory impairment correlates with executive functions disorders and other specific cognitive dysfunctions in Parkinson's disease</article-title><source>Biology</source><year>2023</year><pub-id pub-id-type="pmid">36671804</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/biology12010112</pub-id><pub-id pub-id-type="pmcid">PMC9855400</pub-id></element-citation><mixed-citation id="mc-CR22" publication-type="journal">Solla P, Masala C, Ercoli T, Frau C, Bagella C, Pinna I, Loy F, Defazio G (2023) Olfactory impairment correlates with executive functions disorders and other specific cognitive dysfunctions in Parkinson&#8217;s disease. Biology. 10.3390/biology12010112<pub-id pub-id-type="pmid">36671804</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/biology12010112</pub-id><pub-id pub-id-type="pmcid">PMC9855400</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>R</given-names></name><name name-style="western"><surname>Lian</surname><given-names>T</given-names></name><name name-style="western"><surname>He</surname><given-names>M</given-names></name><name name-style="western"><surname>Guo</surname><given-names>P</given-names></name><name name-style="western"><surname>Yu</surname><given-names>S</given-names></name><name name-style="western"><surname>Zuo</surname><given-names>L</given-names></name><name name-style="western"><surname>Hu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>W</given-names></name></person-group><article-title>Clinical features and neurobiochemical mechanisms of olfactory dysfunction in patients with Parkinson disease</article-title><source>J Neurol</source><year>2024</year><volume>271</volume><fpage>1959</fpage><lpage>1972</lpage><pub-id pub-id-type="pmid">38151574</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00415-023-12122-1</pub-id></element-citation><mixed-citation id="mc-CR23" publication-type="journal">Wang R, Lian T, He M, Guo P, Yu S, Zuo L, Hu Y, Zhang W (2024) Clinical features and neurobiochemical mechanisms of olfactory dysfunction in patients with Parkinson disease. J Neurol 271:1959&#8211;1972<pub-id pub-id-type="pmid">38151574</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00415-023-12122-1</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Roos</surname><given-names>DS</given-names></name><name name-style="western"><surname>Twisk</surname><given-names>JWR</given-names></name><name name-style="western"><surname>Raijmakers</surname><given-names>P</given-names></name><name name-style="western"><surname>Doty</surname><given-names>RL</given-names></name><name name-style="western"><surname>Berendse</surname><given-names>HW</given-names></name></person-group><article-title>Hyposmia as a marker of (non-)motor disease severity in Parkinson's disease</article-title><source>J Neural Transm (Vienna)</source><year>2019</year><volume>126</volume><fpage>1471</fpage><lpage>1478</lpage><pub-id pub-id-type="pmid">31515655</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00702-019-02074-0</pub-id><pub-id pub-id-type="pmcid">PMC6815277</pub-id></element-citation><mixed-citation id="mc-CR24" publication-type="journal">Roos DS, Twisk JWR, Raijmakers P, Doty RL, Berendse HW (2019) Hyposmia as a marker of (non-)motor disease severity in Parkinson&#8217;s disease. J Neural Transm (Vienna) 126:1471&#8211;1478<pub-id pub-id-type="pmid">31515655</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00702-019-02074-0</pub-id><pub-id pub-id-type="pmcid">PMC6815277</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><mixed-citation publication-type="other">Ercoli T, Masala C, Cadeddu G, Mascia MM, Orofino G, Gigante AF, Solla P, Defazio G, Rocchi L (2022) Does Olfactory Dysfunction Correlate with Disease Progression in Parkinson's Disease? A Systematic Review of the Current Literature. Brain Sci 12<pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/brainsci12050513</pub-id><pub-id pub-id-type="pmcid">PMC9139278</pub-id><pub-id pub-id-type="pmid">35624900</pub-id></mixed-citation></ref><ref id="CR26"><label>26.</label><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Roos</surname><given-names>DS</given-names></name><name name-style="western"><surname>Klein</surname><given-names>M</given-names></name><name name-style="western"><surname>Doty</surname><given-names>RL</given-names></name><name name-style="western"><surname>Berendse</surname><given-names>HW</given-names></name></person-group><article-title>Decline of olfactory function in Parkinson's disease: a ten-year longitudinal study</article-title><source>J Parkinson&#8217;s Dis</source><year>2024</year><volume>14</volume><fpage>1877718X241298708</fpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/1877718X241298708</pub-id><pub-id pub-id-type="pmid">40383932</pub-id></element-citation><mixed-citation id="mc-CR26" publication-type="journal">Roos DS, Klein M, Doty RL, Berendse HW (2024) Decline of olfactory function in Parkinson&#8217;s disease: a ten-year longitudinal study. J Parkinson&#8217;s Dis 14:1877718X241298708<pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/1877718X241298708</pub-id><pub-id pub-id-type="pmid">40383932</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>He</surname><given-names>R</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>Y</given-names></name><name name-style="western"><surname>He</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yang</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>X</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>L</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>X</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Z</given-names></name><name name-style="western"><surname>Xu</surname><given-names>Q</given-names></name><name name-style="western"><surname>Sun</surname><given-names>Q</given-names></name><name name-style="western"><surname>Tan</surname><given-names>J</given-names></name><name name-style="western"><surname>Yan</surname><given-names>X</given-names></name><name name-style="western"><surname>Tang</surname><given-names>B</given-names></name><name name-style="western"><surname>Guo</surname><given-names>J</given-names></name></person-group><article-title>Olfactory dysfunction predicts disease progression in Parkinson's Disease: a longitudinal study</article-title><source>Front Neurosci</source><year>2020</year><volume>14</volume><fpage>569777</fpage><pub-id pub-id-type="pmid">33381006</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fnins.2020.569777</pub-id><pub-id pub-id-type="pmcid">PMC7768001</pub-id></element-citation><mixed-citation id="mc-CR27" publication-type="journal">He R, Zhao Y, He Y, Zhou Y, Yang J, Zhou X, Zhu L, Zhou X, Liu Z, Xu Q, Sun Q, Tan J, Yan X, Tang B, Guo J (2020) Olfactory dysfunction predicts disease progression in Parkinson&#8217;s Disease: a longitudinal study. Front Neurosci 14:569777<pub-id pub-id-type="pmid">33381006</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fnins.2020.569777</pub-id><pub-id pub-id-type="pmcid">PMC7768001</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Martinez-Nunez</surname><given-names>AE</given-names></name><name name-style="western"><surname>Latack</surname><given-names>K</given-names></name><name name-style="western"><surname>Situ-Kcomt</surname><given-names>M</given-names></name><name name-style="western"><surname>Mahajan</surname><given-names>A</given-names></name></person-group><article-title>Olfaction and apathy in early idiopathic Parkinson's disease</article-title><source>J Neurol Sci</source><year>2022</year><volume>439</volume><fpage>120314</fpage><pub-id pub-id-type="pmid">35679630</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jns.2022.120314</pub-id></element-citation><mixed-citation id="mc-CR28" publication-type="journal">Martinez-Nunez AE, Latack K, Situ-Kcomt M, Mahajan A (2022) Olfaction and apathy in early idiopathic Parkinson&#8217;s disease. J Neurol Sci 439:120314<pub-id pub-id-type="pmid">35679630</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jns.2022.120314</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fullard</surname><given-names>ME</given-names></name><name name-style="western"><surname>Tran</surname><given-names>B</given-names></name><name name-style="western"><surname>Xie</surname><given-names>SX</given-names></name><name name-style="western"><surname>Toledo</surname><given-names>JB</given-names></name><name name-style="western"><surname>Scordia</surname><given-names>C</given-names></name><name name-style="western"><surname>Linder</surname><given-names>C</given-names></name><name name-style="western"><surname>Purri</surname><given-names>R</given-names></name><name name-style="western"><surname>Weintraub</surname><given-names>D</given-names></name><name name-style="western"><surname>Duda</surname><given-names>JE</given-names></name><name name-style="western"><surname>Chahine</surname><given-names>LM</given-names></name><name name-style="western"><surname>Morley</surname><given-names>JF</given-names></name></person-group><article-title>Olfactory impairment predicts cognitive decline in early Parkinson's disease</article-title><source>Parkinsonism Relat Disord</source><year>2016</year><volume>25</volume><fpage>45</fpage><lpage>51</lpage><pub-id pub-id-type="pmid">26923521</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.parkreldis.2016.02.013</pub-id><pub-id pub-id-type="pmcid">PMC4825674</pub-id></element-citation><mixed-citation id="mc-CR29" publication-type="journal">Fullard ME, Tran B, Xie SX, Toledo JB, Scordia C, Linder C, Purri R, Weintraub D, Duda JE, Chahine LM, Morley JF (2016) Olfactory impairment predicts cognitive decline in early Parkinson&#8217;s disease. Parkinsonism Relat Disord 25:45&#8211;51<pub-id pub-id-type="pmid">26923521</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.parkreldis.2016.02.013</pub-id><pub-id pub-id-type="pmcid">PMC4825674</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Domellof</surname><given-names>ME</given-names></name><name name-style="western"><surname>Lundin</surname><given-names>KF</given-names></name><name name-style="western"><surname>Edstrom</surname><given-names>M</given-names></name><name name-style="western"><surname>Forsgren</surname><given-names>L</given-names></name></person-group><article-title>Olfactory dysfunction and dementia in newly diagnosed patients with Parkinson's disease</article-title><source>Parkinsonism Relat Disord</source><year>2017</year><volume>38</volume><fpage>41</fpage><lpage>47</lpage><pub-id pub-id-type="pmid">28242255</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.parkreldis.2017.02.017</pub-id></element-citation><mixed-citation id="mc-CR30" publication-type="journal">Domellof ME, Lundin KF, Edstrom M, Forsgren L (2017) Olfactory dysfunction and dementia in newly diagnosed patients with Parkinson&#8217;s disease. Parkinsonism Relat Disord 38:41&#8211;47<pub-id pub-id-type="pmid">28242255</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.parkreldis.2017.02.017</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Baba</surname><given-names>T</given-names></name><name name-style="western"><surname>Kikuchi</surname><given-names>A</given-names></name><name name-style="western"><surname>Hirayama</surname><given-names>K</given-names></name><name name-style="western"><surname>Nishio</surname><given-names>Y</given-names></name><name name-style="western"><surname>Hosokai</surname><given-names>Y</given-names></name><name name-style="western"><surname>Kanno</surname><given-names>S</given-names></name><name name-style="western"><surname>Hasegawa</surname><given-names>T</given-names></name><name name-style="western"><surname>Sugeno</surname><given-names>N</given-names></name><name name-style="western"><surname>Konno</surname><given-names>M</given-names></name><name name-style="western"><surname>Suzuki</surname><given-names>K</given-names></name><name name-style="western"><surname>Takahashi</surname><given-names>S</given-names></name><name name-style="western"><surname>Fukuda</surname><given-names>H</given-names></name><name name-style="western"><surname>Aoki</surname><given-names>M</given-names></name><name name-style="western"><surname>Itoyama</surname><given-names>Y</given-names></name><name name-style="western"><surname>Mori</surname><given-names>E</given-names></name><name name-style="western"><surname>Takeda</surname><given-names>A</given-names></name></person-group><article-title>Severe olfactory dysfunction is a prodromal symptom of dementia associated with Parkinson's disease: a 3 year longitudinal study</article-title><source>Brain</source><year>2012</year><volume>135</volume><fpage>161</fpage><lpage>169</lpage><pub-id pub-id-type="pmid">22287381</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/brain/awr321</pub-id></element-citation><mixed-citation id="mc-CR31" publication-type="journal">Baba T, Kikuchi A, Hirayama K, Nishio Y, Hosokai Y, Kanno S, Hasegawa T, Sugeno N, Konno M, Suzuki K, Takahashi S, Fukuda H, Aoki M, Itoyama Y, Mori E, Takeda A (2012) Severe olfactory dysfunction is a prodromal symptom of dementia associated with Parkinson&#8217;s disease: a 3 year longitudinal study. Brain 135:161&#8211;169<pub-id pub-id-type="pmid">22287381</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/brain/awr321</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR32"><label>32.</label><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Braak</surname><given-names>H</given-names></name><name name-style="western"><surname>Del Tredici</surname><given-names>K</given-names></name><name name-style="western"><surname>Rub</surname><given-names>U</given-names></name><name name-style="western"><surname>de Vos</surname><given-names>RA</given-names></name><name name-style="western"><surname>Jansen Steur</surname><given-names>EN</given-names></name><name name-style="western"><surname>Braak</surname><given-names>E</given-names></name></person-group><article-title>Staging of brain pathology related to sporadic Parkinson's disease</article-title><source>Neurobiol Aging</source><year>2003</year><volume>24</volume><fpage>197</fpage><lpage>211</lpage><pub-id pub-id-type="pmid">12498954</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0197-4580(02)00065-9</pub-id></element-citation><mixed-citation id="mc-CR32" publication-type="journal">Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson&#8217;s disease. Neurobiol Aging 24:197&#8211;211<pub-id pub-id-type="pmid">12498954</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0197-4580(02)00065-9</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR33"><label>33.</label><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hughes</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Daniel</surname><given-names>SE</given-names></name><name name-style="western"><surname>Kilford</surname><given-names>L</given-names></name><name name-style="western"><surname>Lees</surname><given-names>AJ</given-names></name></person-group><article-title>Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases</article-title><source>J Neurol Neurosurg Psychiatry</source><year>1992</year><volume>55</volume><fpage>181</fpage><lpage>184</lpage><pub-id pub-id-type="pmid">1564476</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/jnnp.55.3.181</pub-id><pub-id pub-id-type="pmcid">PMC1014720</pub-id></element-citation><mixed-citation id="mc-CR33" publication-type="journal">Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson&#8217;s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181&#8211;184<pub-id pub-id-type="pmid">1564476</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/jnnp.55.3.181</pub-id><pub-id pub-id-type="pmcid">PMC1014720</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR34"><label>34.</label><citation-alternatives><element-citation id="ec-CR34" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Doty</surname><given-names>RL</given-names></name><name name-style="western"><surname>Shaman</surname><given-names>P</given-names></name><name name-style="western"><surname>Dann</surname><given-names>M</given-names></name></person-group><article-title>Development of the University of Pennsylvania smell identification test: a standardized microencapsulated test of olfactory function</article-title><source>Physiol Behav</source><year>1984</year><volume>32</volume><fpage>489</fpage><lpage>502</lpage><pub-id pub-id-type="pmid">6463130</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0031-9384(84)90269-5</pub-id></element-citation><mixed-citation id="mc-CR34" publication-type="journal">Doty RL, Shaman P, Dann M (1984) Development of the University of Pennsylvania smell identification test: a standardized microencapsulated test of olfactory function. Physiol Behav 32:489&#8211;502<pub-id pub-id-type="pmid">6463130</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0031-9384(84)90269-5</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR35"><label>35.</label><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cain</surname><given-names>WS</given-names></name><name name-style="western"><surname>Rabin</surname><given-names>MD</given-names></name></person-group><article-title>Comparability of two tests of olfactory functioning</article-title><source>Chem Senses</source><year>1989</year><volume>14</volume><fpage>479</fpage><lpage>485</lpage></element-citation><mixed-citation id="mc-CR35" publication-type="journal">Cain WS, Rabin MD (1989) Comparability of two tests of olfactory functioning. Chem Senses 14:479&#8211;485</mixed-citation></citation-alternatives></ref><ref id="CR36"><label>36.</label><citation-alternatives><element-citation id="ec-CR36" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fahn</surname><given-names>S</given-names></name><name name-style="western"><surname>Elton</surname><given-names>R</given-names></name></person-group><article-title>UPDRS program members. Unified Parkinson&#8217;s disease rating scale</article-title><source>Recent Dev Parkinson&#8217;s Dis</source><year>1987</year><volume>2</volume><fpage>153</fpage><lpage>163</lpage></element-citation><mixed-citation id="mc-CR36" publication-type="journal">Fahn S, Elton R (1987) UPDRS program members. Unified Parkinson&#8217;s disease rating scale. Recent Dev Parkinson&#8217;s Dis 2:153&#8211;163</mixed-citation></citation-alternatives></ref><ref id="CR37"><label>37.</label><citation-alternatives><element-citation id="ec-CR37" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Goetz</surname><given-names>CG</given-names></name><name name-style="western"><surname>Poewe</surname><given-names>W</given-names></name><name name-style="western"><surname>Rascol</surname><given-names>O</given-names></name><name name-style="western"><surname>Sampaio</surname><given-names>C</given-names></name><name name-style="western"><surname>Stebbins</surname><given-names>GT</given-names></name><name name-style="western"><surname>Counsell</surname><given-names>C</given-names></name><name name-style="western"><surname>Giladi</surname><given-names>N</given-names></name><name name-style="western"><surname>Holloway</surname><given-names>RG</given-names></name><name name-style="western"><surname>Moore</surname><given-names>CG</given-names></name><name name-style="western"><surname>Wenning</surname><given-names>GK</given-names></name><name name-style="western"><surname>Yahr</surname><given-names>MD</given-names></name><name name-style="western"><surname>Seidl</surname><given-names>L</given-names></name><collab>Movement Disorder Society Task Force on Rating Scales for Parkinson's D</collab></person-group><article-title>Movement disorder society task force report on the Hoehn and Yahr staging scale: status and recommendations</article-title><source>Mov Disord</source><year>2004</year><volume>19</volume><fpage>1020</fpage><lpage>1028</lpage><pub-id pub-id-type="pmid">15372591</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/mds.20213</pub-id></element-citation><mixed-citation id="mc-CR37" publication-type="journal">Goetz CG, Poewe W, Rascol O, Sampaio C, Stebbins GT, Counsell C, Giladi N, Holloway RG, Moore CG, Wenning GK, Yahr MD, Seidl L, Movement Disorder Society Task Force on Rating Scales for Parkinson&#8217;s D (2004) Movement disorder society task force report on the Hoehn and Yahr staging scale: status and recommendations. Mov Disord 19:1020&#8211;1028<pub-id pub-id-type="pmid">15372591</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/mds.20213</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR38"><label>38.</label><citation-alternatives><element-citation id="ec-CR38" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tomlinson</surname><given-names>CL</given-names></name><name name-style="western"><surname>Stowe</surname><given-names>R</given-names></name><name name-style="western"><surname>Patel</surname><given-names>S</given-names></name><name name-style="western"><surname>Rick</surname><given-names>C</given-names></name><name name-style="western"><surname>Gray</surname><given-names>R</given-names></name><name name-style="western"><surname>Clarke</surname><given-names>CE</given-names></name></person-group><article-title>Systematic review of levodopa dose equivalency reporting in Parkinson's disease</article-title><source>Mov Disord</source><year>2010</year><volume>25</volume><fpage>2649</fpage><lpage>2653</lpage><pub-id pub-id-type="pmid">21069833</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/mds.23429</pub-id></element-citation><mixed-citation id="mc-CR38" publication-type="journal">Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE (2010) Systematic review of levodopa dose equivalency reporting in Parkinson&#8217;s disease. Mov Disord 25:2649&#8211;2653<pub-id pub-id-type="pmid">21069833</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/mds.23429</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR39"><label>39.</label><citation-alternatives><element-citation id="ec-CR39" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Folstein</surname><given-names>MF</given-names></name><name name-style="western"><surname>Folstein</surname><given-names>SE</given-names></name><name name-style="western"><surname>McHugh</surname><given-names>PR</given-names></name></person-group><article-title>"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician</article-title><source>J Psychiatr Res</source><year>1975</year><volume>12</volume><fpage>189</fpage><lpage>198</lpage><pub-id pub-id-type="pmid">1202204</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0022-3956(75)90026-6</pub-id></element-citation><mixed-citation id="mc-CR39" publication-type="journal">Folstein MF, Folstein SE, McHugh PR (1975) &#8220;Mini-mental state&#8221;. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189&#8211;198<pub-id pub-id-type="pmid">1202204</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0022-3956(75)90026-6</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR40"><label>40.</label><citation-alternatives><element-citation id="ec-CR40" publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Wechsler</surname><given-names>D</given-names></name></person-group><source>Wechsler Adult Intelligence Scale-III/Wechsler Memory Scale-Third Edition San Antonio</source><year>1997</year><publisher-loc>TX</publisher-loc><publisher-name>Technical Manual The Psychological Corporation</publisher-name></element-citation><mixed-citation id="mc-CR40" publication-type="book">Wechsler D (1997) Wechsler Adult Intelligence Scale-III/Wechsler Memory Scale-Third Edition San Antonio. Technical Manual The Psychological Corporation, TX</mixed-citation></citation-alternatives></ref><ref id="CR41"><label>41.</label><citation-alternatives><element-citation id="ec-CR41" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stroop</surname><given-names>JR</given-names></name></person-group><article-title>Studies of interference in serial verbal reactions</article-title><source>J Exp Psychol</source><year>1935</year><volume>18</volume><fpage>643</fpage></element-citation><mixed-citation id="mc-CR41" publication-type="journal">Stroop JR (1935) Studies of interference in serial verbal reactions. J Exp Psychol 18:643</mixed-citation></citation-alternatives></ref><ref id="CR42"><label>42.</label><citation-alternatives><element-citation id="ec-CR42" publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Benton</surname><given-names>A</given-names></name><name name-style="western"><surname>Hamsher</surname><given-names>K</given-names></name><name name-style="western"><surname>Sivan</surname><given-names>A</given-names></name></person-group><source>Multilingual Aphasia Examination</source><year>1994</year><publisher-loc>Iowa IA</publisher-loc><publisher-name>AJA Associates</publisher-name></element-citation><mixed-citation id="mc-CR42" publication-type="book">Benton A, Hamsher K, Sivan A (1994) Multilingual Aphasia Examination. AJA Associates, Iowa IA</mixed-citation></citation-alternatives></ref><ref id="CR43"><label>43.</label><citation-alternatives><element-citation id="ec-CR43" publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Schmidt</surname><given-names>M</given-names></name></person-group><source>Rey auditory verbal learning test: A handbook</source><year>1996</year><publisher-loc>Western Psychological Services Los Angeles</publisher-loc><publisher-name>CA</publisher-name></element-citation><mixed-citation id="mc-CR43" publication-type="book">Schmidt M (1996) Rey auditory verbal learning test: A handbook. CA, Western Psychological Services Los Angeles</mixed-citation></citation-alternatives></ref><ref id="CR44"><label>44.</label><citation-alternatives><element-citation id="ec-CR44" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Verhage</surname><given-names>F</given-names></name></person-group><article-title>Intelligence and age in a Dutch sample</article-title><source>Hum Dev</source><year>1965</year><volume>8</volume><fpage>238</fpage><lpage>245</lpage></element-citation><mixed-citation id="mc-CR44" publication-type="journal">Verhage F (1965) Intelligence and age in a Dutch sample. Hum Dev 8:238&#8211;245</mixed-citation></citation-alternatives></ref><ref id="CR45"><label>45.</label><citation-alternatives><element-citation id="ec-CR45" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Visser</surname><given-names>M</given-names></name><name name-style="western"><surname>Marinus</surname><given-names>J</given-names></name><name name-style="western"><surname>Stiggelbout</surname><given-names>AM</given-names></name><name name-style="western"><surname>Van Hilten</surname><given-names>JJ</given-names></name></person-group><article-title>Assessment of autonomic dysfunction in Parkinson's disease: the SCOPA-AUT</article-title><source>Mov Disord</source><year>2004</year><volume>19</volume><fpage>1306</fpage><lpage>1312</lpage><pub-id pub-id-type="pmid">15390007</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/mds.20153</pub-id></element-citation><mixed-citation id="mc-CR45" publication-type="journal">Visser M, Marinus J, Stiggelbout AM, Van Hilten JJ (2004) Assessment of autonomic dysfunction in Parkinson&#8217;s disease: the SCOPA-AUT. Mov Disord 19:1306&#8211;1312<pub-id pub-id-type="pmid">15390007</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/mds.20153</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR46"><label>46.</label><citation-alternatives><element-citation id="ec-CR46" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Marinus</surname><given-names>J</given-names></name><name name-style="western"><surname>Visser</surname><given-names>M</given-names></name><name name-style="western"><surname>van Hilten</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Lammers</surname><given-names>GJ</given-names></name><name name-style="western"><surname>Stiggelbout</surname><given-names>AM</given-names></name></person-group><article-title>Assessment of sleep and sleepiness in Parkinson disease</article-title><source>Sleep</source><year>2003</year><volume>26</volume><fpage>1049</fpage><lpage>1054</lpage><pub-id pub-id-type="pmid">14746389</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/sleep/26.8.1049</pub-id></element-citation><mixed-citation id="mc-CR46" publication-type="journal">Marinus J, Visser M, van Hilten JJ, Lammers GJ, Stiggelbout AM (2003) Assessment of sleep and sleepiness in Parkinson disease. Sleep 26:1049&#8211;1054<pub-id pub-id-type="pmid">14746389</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/sleep/26.8.1049</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR47"><label>47.</label><citation-alternatives><element-citation id="ec-CR47" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Visser</surname><given-names>M</given-names></name><name name-style="western"><surname>Verbaan</surname><given-names>D</given-names></name><name name-style="western"><surname>van Rooden</surname><given-names>SM</given-names></name><name name-style="western"><surname>Stiggelbout</surname><given-names>AM</given-names></name><name name-style="western"><surname>Marinus</surname><given-names>J</given-names></name><name name-style="western"><surname>van Hilten</surname><given-names>JJ</given-names></name></person-group><article-title>Assessment of psychiatric complications in Parkinson's disease: the SCOPA-PC</article-title><source>Mov Disord</source><year>2007</year><volume>22</volume><issue>15</issue><fpage>2221</fpage><lpage>2228</lpage><pub-id pub-id-type="pmid">17712843</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/mds.21696</pub-id></element-citation><mixed-citation id="mc-CR47" publication-type="journal">Visser M, Verbaan D, van Rooden SM, Stiggelbout AM, Marinus J, van Hilten JJ (2007) Assessment of psychiatric complications in Parkinson&#8217;s disease: the SCOPA-PC. Mov Disord 22(15):2221&#8211;2228<pub-id pub-id-type="pmid">17712843</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/mds.21696</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR48"><label>48.</label><citation-alternatives><element-citation id="ec-CR48" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Beck</surname><given-names>AT</given-names></name><name name-style="western"><surname>Ward</surname><given-names>CH</given-names></name><name name-style="western"><surname>Mendelson</surname><given-names>M</given-names></name><name name-style="western"><surname>Mock</surname><given-names>J</given-names></name><name name-style="western"><surname>Erbaugh</surname><given-names>J</given-names></name></person-group><article-title>An inventory for measuring depression</article-title><source>Arch Gen Psychiatry</source><year>1961</year><volume>4</volume><fpage>561</fpage><lpage>571</lpage><pub-id pub-id-type="pmid">13688369</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/archpsyc.1961.01710120031004</pub-id></element-citation><mixed-citation id="mc-CR48" publication-type="journal">Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561&#8211;571<pub-id pub-id-type="pmid">13688369</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/archpsyc.1961.01710120031004</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR49"><label>49.</label><citation-alternatives><element-citation id="ec-CR49" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Beck</surname><given-names>AT</given-names></name><name name-style="western"><surname>Epstein</surname><given-names>N</given-names></name><name name-style="western"><surname>Brown</surname><given-names>G</given-names></name><name name-style="western"><surname>Steer</surname><given-names>RA</given-names></name></person-group><article-title>An inventory for measuring clinical anxiety: psychometric properties</article-title><source>J Consult Clin Psychol</source><year>1988</year><volume>56</volume><fpage>893</fpage><lpage>897</lpage><pub-id pub-id-type="pmid">3204199</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1037//0022-006x.56.6.893</pub-id></element-citation><mixed-citation id="mc-CR49" publication-type="journal">Beck AT, Epstein N, Brown G, Steer RA (1988) An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 56:893&#8211;897<pub-id pub-id-type="pmid">3204199</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1037//0022-006x.56.6.893</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR50"><label>50.</label><citation-alternatives><element-citation id="ec-CR50" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Herting</surname><given-names>B</given-names></name><name name-style="western"><surname>Schulze</surname><given-names>S</given-names></name><name name-style="western"><surname>Reichmann</surname><given-names>H</given-names></name><name name-style="western"><surname>Haehner</surname><given-names>A</given-names></name><name name-style="western"><surname>Hummel</surname><given-names>T</given-names></name></person-group><article-title>A longitudinal study of olfactory function in patients with idiopathic Parkinson's disease</article-title><source>J Neurol</source><year>2008</year><volume>255</volume><fpage>367</fpage><lpage>370</lpage><pub-id pub-id-type="pmid">18343969</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00415-008-0665-5</pub-id></element-citation><mixed-citation id="mc-CR50" publication-type="journal">Herting B, Schulze S, Reichmann H, Haehner A, Hummel T (2008) A longitudinal study of olfactory function in patients with idiopathic Parkinson&#8217;s disease. J Neurol 255:367&#8211;370<pub-id pub-id-type="pmid">18343969</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00415-008-0665-5</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR51"><label>51.</label><citation-alternatives><element-citation id="ec-CR51" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Henry</surname><given-names>JD</given-names></name><name name-style="western"><surname>Crawford</surname><given-names>JR</given-names></name></person-group><article-title>A meta-analytic review of verbal fluency performance following focal cortical lesions</article-title><source>Neuropsychology</source><year>2004</year><volume>18</volume><fpage>284</fpage><lpage>295</lpage><pub-id pub-id-type="pmid">15099151</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1037/0894-4105.18.2.284</pub-id></element-citation><mixed-citation id="mc-CR51" publication-type="journal">Henry JD, Crawford JR (2004) A meta-analytic review of verbal fluency performance following focal cortical lesions. Neuropsychology 18:284&#8211;295<pub-id pub-id-type="pmid">15099151</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1037/0894-4105.18.2.284</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR52"><label>52.</label><citation-alternatives><element-citation id="ec-CR52" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schmidt</surname><given-names>CSM</given-names></name><name name-style="western"><surname>Schumacher</surname><given-names>LV</given-names></name><name name-style="western"><surname>Romer</surname><given-names>P</given-names></name><name name-style="western"><surname>Leonhart</surname><given-names>R</given-names></name><name name-style="western"><surname>Beume</surname><given-names>L</given-names></name><name name-style="western"><surname>Martin</surname><given-names>M</given-names></name><name name-style="western"><surname>Dressing</surname><given-names>A</given-names></name><name name-style="western"><surname>Weiller</surname><given-names>C</given-names></name><name name-style="western"><surname>Kaller</surname><given-names>CP</given-names></name></person-group><article-title>Are semantic and phonological fluency based on the same or distinct sets of cognitive processes? Insights from factor analyses in healthy adults and stroke patients</article-title><source>Neuropsychologia</source><year>2017</year><volume>99</volume><fpage>148</fpage><lpage>155</lpage><pub-id pub-id-type="pmid">28257876</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.neuropsychologia.2017.02.019</pub-id></element-citation><mixed-citation id="mc-CR52" publication-type="journal">Schmidt CSM, Schumacher LV, Romer P, Leonhart R, Beume L, Martin M, Dressing A, Weiller C, Kaller CP (2017) Are semantic and phonological fluency based on the same or distinct sets of cognitive processes? Insights from factor analyses in healthy adults and stroke patients. Neuropsychologia 99:148&#8211;155<pub-id pub-id-type="pmid">28257876</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.neuropsychologia.2017.02.019</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR53"><label>53.</label><citation-alternatives><element-citation id="ec-CR53" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Biesbroek</surname><given-names>JM</given-names></name><name name-style="western"><surname>van Zandvoort</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Kappelle</surname><given-names>LJ</given-names></name><name name-style="western"><surname>Velthuis</surname><given-names>BK</given-names></name><name name-style="western"><surname>Biessels</surname><given-names>GJ</given-names></name><name name-style="western"><surname>Postma</surname><given-names>A</given-names></name></person-group><article-title>Shared and distinct anatomical correlates of semantic and phonemic fluency revealed by lesion-symptom mapping in patients with ischemic stroke</article-title><source>Brain Struct Funct</source><year>2016</year><volume>221</volume><fpage>2123</fpage><lpage>2134</lpage><pub-id pub-id-type="pmid">25939335</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00429-015-1033-8</pub-id><pub-id pub-id-type="pmcid">PMC4853441</pub-id></element-citation><mixed-citation id="mc-CR53" publication-type="journal">Biesbroek JM, van Zandvoort MJ, Kappelle LJ, Velthuis BK, Biessels GJ, Postma A (2016) Shared and distinct anatomical correlates of semantic and phonemic fluency revealed by lesion-symptom mapping in patients with ischemic stroke. Brain Struct Funct 221:2123&#8211;2134<pub-id pub-id-type="pmid">25939335</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00429-015-1033-8</pub-id><pub-id pub-id-type="pmcid">PMC4853441</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR54"><label>54.</label><citation-alternatives><element-citation id="ec-CR54" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chouiter</surname><given-names>L</given-names></name><name name-style="western"><surname>Holmberg</surname><given-names>J</given-names></name><name name-style="western"><surname>Manuel</surname><given-names>AL</given-names></name><name name-style="western"><surname>Colombo</surname><given-names>F</given-names></name><name name-style="western"><surname>Clarke</surname><given-names>S</given-names></name><name name-style="western"><surname>Annoni</surname><given-names>JM</given-names></name><name name-style="western"><surname>Spierer</surname><given-names>L</given-names></name></person-group><article-title>Partly segregated cortico-subcortical pathways support phonologic and semantic verbal fluency: a lesion study</article-title><source>Neuroscience</source><year>2016</year><volume>329</volume><fpage>275</fpage><lpage>283</lpage><pub-id pub-id-type="pmid">27217213</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.neuroscience.2016.05.029</pub-id></element-citation><mixed-citation id="mc-CR54" publication-type="journal">Chouiter L, Holmberg J, Manuel AL, Colombo F, Clarke S, Annoni JM, Spierer L (2016) Partly segregated cortico-subcortical pathways support phonologic and semantic verbal fluency: a lesion study. Neuroscience 329:275&#8211;283<pub-id pub-id-type="pmid">27217213</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.neuroscience.2016.05.029</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR55"><label>55.</label><citation-alternatives><element-citation id="ec-CR55" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Baldo</surname><given-names>JV</given-names></name><name name-style="western"><surname>Schwartz</surname><given-names>S</given-names></name><name name-style="western"><surname>Wilkins</surname><given-names>D</given-names></name><name name-style="western"><surname>Dronkers</surname><given-names>NF</given-names></name></person-group><article-title>Role of frontal versus temporal cortex in verbal fluency as revealed by voxel-based lesion symptom mapping</article-title><source>J Int Neuropsychol Soc</source><year>2006</year><volume>12</volume><fpage>896</fpage><lpage>900</lpage><pub-id pub-id-type="pmid">17064451</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1017/S1355617706061078</pub-id></element-citation><mixed-citation id="mc-CR55" publication-type="journal">Baldo JV, Schwartz S, Wilkins D, Dronkers NF (2006) Role of frontal versus temporal cortex in verbal fluency as revealed by voxel-based lesion symptom mapping. J Int Neuropsychol Soc 12:896&#8211;900<pub-id pub-id-type="pmid">17064451</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1017/S1355617706061078</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR56"><label>56.</label><citation-alternatives><element-citation id="ec-CR56" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Robinson</surname><given-names>G</given-names></name><name name-style="western"><surname>Shallice</surname><given-names>T</given-names></name><name name-style="western"><surname>Bozzali</surname><given-names>M</given-names></name><name name-style="western"><surname>Cipolotti</surname><given-names>L</given-names></name></person-group><article-title>The differing roles of the frontal cortex in fluency tests</article-title><source>Brain</source><year>2012</year><volume>135</volume><fpage>2202</fpage><lpage>2214</lpage><pub-id pub-id-type="pmid">22669082</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/brain/aws142</pub-id><pub-id pub-id-type="pmcid">PMC3381725</pub-id></element-citation><mixed-citation id="mc-CR56" publication-type="journal">Robinson G, Shallice T, Bozzali M, Cipolotti L (2012) The differing roles of the frontal cortex in fluency tests. Brain 135:2202&#8211;2214<pub-id pub-id-type="pmid">22669082</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/brain/aws142</pub-id><pub-id pub-id-type="pmcid">PMC3381725</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR57"><label>57.</label><citation-alternatives><element-citation id="ec-CR57" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Baldo</surname><given-names>JV</given-names></name><name name-style="western"><surname>Schwartz</surname><given-names>S</given-names></name><name name-style="western"><surname>Wilkins</surname><given-names>DP</given-names></name><name name-style="western"><surname>Dronkers</surname><given-names>NF</given-names></name></person-group><article-title>Double dissociation of letter and category fluency following left frontal and temporal lobe lesions</article-title><source>Aphasiology</source><year>2010</year><volume>24</volume><fpage>1593</fpage><lpage>1604</lpage></element-citation><mixed-citation id="mc-CR57" publication-type="journal">Baldo JV, Schwartz S, Wilkins DP, Dronkers NF (2010) Double dissociation of letter and category fluency following left frontal and temporal lobe lesions. Aphasiology 24:1593&#8211;1604</mixed-citation></citation-alternatives></ref><ref id="CR58"><label>58.</label><citation-alternatives><element-citation id="ec-CR58" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Williams-Gray</surname><given-names>CH</given-names></name><name name-style="western"><surname>Evans</surname><given-names>JR</given-names></name><name name-style="western"><surname>Goris</surname><given-names>A</given-names></name><name name-style="western"><surname>Foltynie</surname><given-names>T</given-names></name><name name-style="western"><surname>Ban</surname><given-names>M</given-names></name><name name-style="western"><surname>Robbins</surname><given-names>TW</given-names></name><name name-style="western"><surname>Brayne</surname><given-names>C</given-names></name><name name-style="western"><surname>Kolachana</surname><given-names>BS</given-names></name><name name-style="western"><surname>Weinberger</surname><given-names>DR</given-names></name><name name-style="western"><surname>Sawcer</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Barker</surname><given-names>RA</given-names></name></person-group><article-title>The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort</article-title><source>Brain</source><year>2009</year><volume>132</volume><fpage>2958</fpage><lpage>2969</lpage><pub-id pub-id-type="pmid">19812213</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/brain/awp245</pub-id></element-citation><mixed-citation id="mc-CR58" publication-type="journal">Williams-Gray CH, Evans JR, Goris A, Foltynie T, Ban M, Robbins TW, Brayne C, Kolachana BS, Weinberger DR, Sawcer SJ, Barker RA (2009) The distinct cognitive syndromes of Parkinson&#8217;s disease: 5 year follow-up of the CamPaIGN cohort. Brain 132:2958&#8211;2969<pub-id pub-id-type="pmid">19812213</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/brain/awp245</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR59"><label>59.</label><citation-alternatives><element-citation id="ec-CR59" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Doty</surname><given-names>RL</given-names></name></person-group><article-title>Olfactory dysfunction in Parkinson disease</article-title><source>Nat Rev Neurol</source><year>2012</year><volume>8</volume><fpage>329</fpage><lpage>339</lpage><pub-id pub-id-type="pmid">22584158</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nrneurol.2012.80</pub-id></element-citation><mixed-citation id="mc-CR59" publication-type="journal">Doty RL (2012) Olfactory dysfunction in Parkinson disease. Nat Rev Neurol 8:329&#8211;339<pub-id pub-id-type="pmid">22584158</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nrneurol.2012.80</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR60"><label>60.</label><citation-alternatives><element-citation id="ec-CR60" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Devanand</surname><given-names>DP</given-names></name><name name-style="western"><surname>Liu</surname><given-names>X</given-names></name><name name-style="western"><surname>Tabert</surname><given-names>MH</given-names></name><name name-style="western"><surname>Pradhaban</surname><given-names>G</given-names></name><name name-style="western"><surname>Cuasay</surname><given-names>K</given-names></name><name name-style="western"><surname>Bell</surname><given-names>K</given-names></name><name name-style="western"><surname>de Leon</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Doty</surname><given-names>RL</given-names></name><name name-style="western"><surname>Stern</surname><given-names>Y</given-names></name><name name-style="western"><surname>Pelton</surname><given-names>GH</given-names></name></person-group><article-title>Combining early markers strongly predicts conversion from mild cognitive impairment to Alzheimer's disease</article-title><source>Biol Psychiatry</source><year>2008</year><volume>64</volume><fpage>871</fpage><lpage>879</lpage><pub-id pub-id-type="pmid">18723162</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.biopsych.2008.06.020</pub-id><pub-id pub-id-type="pmcid">PMC2613777</pub-id></element-citation><mixed-citation id="mc-CR60" publication-type="journal">Devanand DP, Liu X, Tabert MH, Pradhaban G, Cuasay K, Bell K, de Leon MJ, Doty RL, Stern Y, Pelton GH (2008) Combining early markers strongly predicts conversion from mild cognitive impairment to Alzheimer&#8217;s disease. Biol Psychiatry 64:871&#8211;879<pub-id pub-id-type="pmid">18723162</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.biopsych.2008.06.020</pub-id><pub-id pub-id-type="pmcid">PMC2613777</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR61"><label>61.</label><citation-alternatives><element-citation id="ec-CR61" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brumm</surname><given-names>MC</given-names></name><name name-style="western"><surname>Pierz</surname><given-names>KA</given-names></name><name name-style="western"><surname>Lafontant</surname><given-names>DE</given-names></name><name name-style="western"><surname>Caspell-Garcia</surname><given-names>C</given-names></name><name name-style="western"><surname>Coffey</surname><given-names>CS</given-names></name><name name-style="western"><surname>Siderowf</surname><given-names>A</given-names></name><name name-style="western"><surname>Marek</surname><given-names>K</given-names></name></person-group><article-title>Updated percentiles for the University of Pennsylvania smell identification test in adults 50 years of age and older</article-title><source>Neurology</source><year>2023</year><volume>100</volume><fpage>e1691</fpage><lpage>e1701</lpage><pub-id pub-id-type="pmid">36849448</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1212/WNL.0000000000207077</pub-id><pub-id pub-id-type="pmcid">PMC10115503</pub-id></element-citation><mixed-citation id="mc-CR61" publication-type="journal">Brumm MC, Pierz KA, Lafontant DE, Caspell-Garcia C, Coffey CS, Siderowf A, Marek K (2023) Updated percentiles for the University of Pennsylvania smell identification test in adults 50 years of age and older. Neurology 100:e1691&#8211;e1701<pub-id pub-id-type="pmid">36849448</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1212/WNL.0000000000207077</pub-id><pub-id pub-id-type="pmcid">PMC10115503</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR62"><label>62.</label><citation-alternatives><element-citation id="ec-CR62" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Doty</surname><given-names>RL</given-names></name><name name-style="western"><surname>Wylie</surname><given-names>C</given-names></name><name name-style="western"><surname>Potter</surname><given-names>M</given-names></name><name name-style="western"><surname>Beston</surname><given-names>R</given-names></name><name name-style="western"><surname>Cope</surname><given-names>B</given-names></name><name name-style="western"><surname>Majam</surname><given-names>K</given-names></name></person-group><article-title>Clinical validation of the olfactory detection threshold module of the snap &amp; sniff(R) olfactory test system</article-title><source>Int Forum Allergy Rhinol</source><year>2019</year><volume>9</volume><fpage>986</fpage><lpage>992</lpage><pub-id pub-id-type="pmid">31283113</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/alr.22377</pub-id></element-citation><mixed-citation id="mc-CR62" publication-type="journal">Doty RL, Wylie C, Potter M, Beston R, Cope B, Majam K (2019) Clinical validation of the olfactory detection threshold module of the snap &amp; sniff(R) olfactory test system. Int Forum Allergy Rhinol 9:986&#8211;992<pub-id pub-id-type="pmid">31283113</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/alr.22377</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR63"><label>63.</label><citation-alternatives><element-citation id="ec-CR63" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Litvan</surname><given-names>I</given-names></name><name name-style="western"><surname>Goldman</surname><given-names>JG</given-names></name><name name-style="western"><surname>Troster</surname><given-names>AI</given-names></name><name name-style="western"><surname>Schmand</surname><given-names>BA</given-names></name><name name-style="western"><surname>Weintraub</surname><given-names>D</given-names></name><name name-style="western"><surname>Petersen</surname><given-names>RC</given-names></name><name name-style="western"><surname>Mollenhauer</surname><given-names>B</given-names></name><name name-style="western"><surname>Adler</surname><given-names>CH</given-names></name><name name-style="western"><surname>Marder</surname><given-names>K</given-names></name><name name-style="western"><surname>Williams-Gray</surname><given-names>CH</given-names></name><name name-style="western"><surname>Aarsland</surname><given-names>D</given-names></name><name name-style="western"><surname>Kulisevsky</surname><given-names>J</given-names></name><name name-style="western"><surname>Rodriguez-Oroz</surname><given-names>MC</given-names></name><name name-style="western"><surname>Burn</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Barker</surname><given-names>RA</given-names></name><name name-style="western"><surname>Emre</surname><given-names>M</given-names></name></person-group><article-title>Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement disorder society task force guidelines</article-title><source>Mov Disord</source><year>2012</year><volume>27</volume><fpage>349</fpage><lpage>356</lpage><pub-id pub-id-type="pmid">22275317</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/mds.24893</pub-id><pub-id pub-id-type="pmcid">PMC3641655</pub-id></element-citation><mixed-citation id="mc-CR63" publication-type="journal">Litvan I, Goldman JG, Troster AI, Schmand BA, Weintraub D, Petersen RC, Mollenhauer B, Adler CH, Marder K, Williams-Gray CH, Aarsland D, Kulisevsky J, Rodriguez-Oroz MC, Burn DJ, Barker RA, Emre M (2012) Diagnostic criteria for mild cognitive impairment in Parkinson&#8217;s disease: Movement disorder society task force guidelines. Mov Disord 27:349&#8211;356<pub-id pub-id-type="pmid">22275317</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/mds.24893</pub-id><pub-id pub-id-type="pmcid">PMC3641655</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR64"><label>64.</label><citation-alternatives><element-citation id="ec-CR64" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Emre</surname><given-names>M</given-names></name><name name-style="western"><surname>Aarsland</surname><given-names>D</given-names></name><name name-style="western"><surname>Brown</surname><given-names>R</given-names></name><name name-style="western"><surname>Burn</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Duyckaerts</surname><given-names>C</given-names></name><name name-style="western"><surname>Mizuno</surname><given-names>Y</given-names></name><name name-style="western"><surname>Broe</surname><given-names>GA</given-names></name><name name-style="western"><surname>Cummings</surname><given-names>J</given-names></name><name name-style="western"><surname>Dickson</surname><given-names>DW</given-names></name><name name-style="western"><surname>Gauthier</surname><given-names>S</given-names></name><name name-style="western"><surname>Goldman</surname><given-names>J</given-names></name><name name-style="western"><surname>Goetz</surname><given-names>C</given-names></name><name name-style="western"><surname>Korczyn</surname><given-names>A</given-names></name><name name-style="western"><surname>Lees</surname><given-names>A</given-names></name><name name-style="western"><surname>Levy</surname><given-names>R</given-names></name><name name-style="western"><surname>Litvan</surname><given-names>I</given-names></name><name name-style="western"><surname>McKeith</surname><given-names>I</given-names></name><name name-style="western"><surname>Olanow</surname><given-names>W</given-names></name><name name-style="western"><surname>Poewe</surname><given-names>W</given-names></name><name name-style="western"><surname>Quinn</surname><given-names>N</given-names></name><name name-style="western"><surname>Sampaio</surname><given-names>C</given-names></name><name name-style="western"><surname>Tolosa</surname><given-names>E</given-names></name><name name-style="western"><surname>Dubois</surname><given-names>B</given-names></name></person-group><article-title>Clinical diagnostic criteria for dementia associated with Parkinson's disease</article-title><source>Mov Disord</source><year>2007</year><volume>22</volume><fpage>1689</fpage><lpage>1707</lpage><pub-id pub-id-type="pmid">17542011</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/mds.21507</pub-id></element-citation><mixed-citation id="mc-CR64" publication-type="journal">Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y, Broe GA, Cummings J, Dickson DW, Gauthier S, Goldman J, Goetz C, Korczyn A, Lees A, Levy R, Litvan I, McKeith I, Olanow W, Poewe W, Quinn N, Sampaio C, Tolosa E, Dubois B (2007) Clinical diagnostic criteria for dementia associated with Parkinson&#8217;s disease. Mov Disord 22:1689&#8211;1707<pub-id pub-id-type="pmid">17542011</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/mds.21507</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR65"><label>65.</label><citation-alternatives><element-citation id="ec-CR65" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Siderowf</surname><given-names>A</given-names></name><name name-style="western"><surname>Jennings</surname><given-names>D</given-names></name><name name-style="western"><surname>Connolly</surname><given-names>J</given-names></name><name name-style="western"><surname>Doty</surname><given-names>RL</given-names></name><name name-style="western"><surname>Marek</surname><given-names>K</given-names></name><name name-style="western"><surname>Stern</surname><given-names>MB</given-names></name></person-group><article-title>Risk factors for Parkinson's disease and impaired olfaction in relatives of patients with Parkinson's disease</article-title><source>Mov Disord</source><year>2007</year><volume>22</volume><fpage>2249</fpage><lpage>2255</lpage><pub-id pub-id-type="pmid">17876851</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/mds.21707</pub-id></element-citation><mixed-citation id="mc-CR65" publication-type="journal">Siderowf A, Jennings D, Connolly J, Doty RL, Marek K, Stern MB (2007) Risk factors for Parkinson&#8217;s disease and impaired olfaction in relatives of patients with Parkinson&#8217;s disease. Mov Disord 22:2249&#8211;2255<pub-id pub-id-type="pmid">17876851</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/mds.21707</pub-id></mixed-citation></citation-alternatives></ref></ref-list></back></article>
        
    </metadata>
</record>
    </GetRecord>

</OAI-PMH>